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Abstract 
 Type 2 Diabetes (DM 2) is increasingly prevalent worldwide. Its potential for debilitating 
long-term sequelae and subsequent burden on healthcare systems highlight the importance of 
adequate diabetes management. Glucose control remains central to treatment and often includes 
nutritional therapy, pharmacotherapy and self-management strategies. Individuals with DM 2 
who experience food insecurity (FI) are at an increased risk of poorly managed diabetes. Nurse 
practitioners in primary care are specifically skilled at identifying patient difficulties in making, 
adopting and adhering to lifestyle changes, thus are ideally positioned to address barriers to 
chronic disease management. However, it remains unclear how FI influences DM 2 and how it is 
accurately identified in the primary care setting. An integrative literature review was completed 
to identify which strategies nurse practitioners can employ in primary care to identify and thus 
enhance the management of DM 2 among patients experiencing FI. With the guidance of 
Whittemore and Knalf’s approach to integrative reviews and the incorporation of Maslow’s 
Theory of Motivation (MTM), a literature analysis was conducted revealing a complex 
relationship between FI and the management of DM 2. The review highlights how FI interferes 
with an individual’s capacity to self-manage their DM 2 by influencing food behaviors, 
medication use and mental health. MTM highlights prerequisite needs necessary for diabetes 
self-management amongst individuals experiencing FI. Challenges in identifying FI in practice 
are identified, along with strategies to incorporate into practice. Important interventions and 
clinical recommendations are discussed including: assessing for dysglycemia, assessing for 
depression and distress, pharmacological management, social support and resource allocation. 
All are important approaches that nurse practitioners can incorporate in the primary care setting. 
Finally, limitations and areas for future research are discussed. 
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Glossary of Terms 
Canadian Community Health Survey (CCHS):  National survey comprised of both pan-Canadian 
 annual surveys and focused surveys directed at 35,000 Canadians every 3 years. The 
 purpose is to extract population-level information on the health determinants, health 
 status and health system utilization of Canadians. The CCHS is a collaborative effort 
 between Health Canada, the Public Health Agency of Canada (PHAC), Statistics Canada 
 (SC), and the Canadian Institute for Health Information (CIHI) (Government of Canada, 
 2017). 
Diabetes Canada (DC): The national association for diabetes in Canada that advocates on behalf 
 of individuals with diabetes and supports Canadians, their care providers and research, 
 which is aimed at living healthy lives, preventing diabetes-associated complications  
            and finding a cure. (Diabetes Canada, 2019). 
Diabetes Distress (DD): Negative emotions and feelings such as despondency and turmoil, and the 
 perceived burden of living with and managing diabetes. Particularly, diabetes distress usually 
 refers to the pressure felt to monitor, treat, and worry about complications on a  
              continuous basis (Robinson et al., 2018) 
Depression: Refers to the experience of individuals who present with persistent depressive 
 feelings and feelings of low mood, which interferes with daily living, as well as of 
 individuals meeting the DSM-V criteria for major depressive disorder (MDD).  
Fair Pharmacare: The only Pharmacare plan eligible to all residents of B.C. with active Medical 
 Service Plan (MSP) B.C. accounts. Fair Pharmacare is income-based, meaning families 
 with lesser income receive more help with the cost of Pharmacare-approved drugs, 
 supplies and dispensing fees (Government of British Columbia, 2018a). 
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Food Insecurity: Defined differently throughout the literature. With respect to diabetes it 
 generally refers to uncertain access and consumption of nutritionally adequate food in 
 sufficient quantities, and usually the result of many complex sociopolitical interactions. 
Glycated Hemoglobin (A1C): HB A1C is used as an estimate of mean plasma glucose (or 
 glucose control) over the previous 8-12 weeks. Fifty percent of the value is derived from 
 the preceding 30 days, while only 10% of the value is derived from the prior 90 to 120 
 days. The A1C is used for diabetes diagnosis, and monitoring of treatment effectiveness. 
 DC provides evidence-based guidelines for A1C monitoring (Berard, Siemens, & Woo, 
 2018). 
Medical Services Plan (MSP): The name of publicly funded health insurance in British 
 Columbia, which covers the costs of all medically-necessary care provider services. All 
 residents of B.C. are eligible (Government of British Columbia, 2018f). 
Nurse Practitioner: A graduate-prepared registered nurse who obtained advanced knowledge for 
 autonomous practice by completing either an accredited family or acute care nurse 
 practitioner (NP) master’s program. NPs possess competencies in health management 
 provision, ordering and interpreting diagnostic tests, diagnosing and treating, providing 
 disease prevention, health promotion and health management (Canadian Nurses 
 Association [CNA], 2010). 
Pharmacare: A publicly funded medication and supply program through the government of B.C., 
 assisting its residents with active Medical Services Plan of B.C. (MSP) coverage, with the 
 costs of prescription medications and supplies that are eligible within the program. 
 Residents are eligible under one of several plans (Government of British Columbia, 
 2018a). 
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Primary Care Provider: Health care provider (physician, nurse practitioner or) who is most 
 responsible for the care of a patient in the community setting, usually over an extended 
 period of time.  
Special Authority (SA) Coverage: Refers to when Pharmacare provides full or partial benefits to 
 a drug or medical supplies previously not covered, and when the drug’s eligibility criteria 
 has been met and SA forms have been sent to Pharmacare. The level of reimbursement is 
 still dependent upon annual deductible requirements (Government of British Columbia, 
 2018g). 
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Chapter 1 
Introduction  
 Type 2 diabetes mellitus (DM 2) is a chronic metabolic disease with increasing 
worldwide prevalence (Vas et al., 2017).  In Canada, the prevalence of DM 2 is projected to 
reach 10.8% by 2020 (Canadian Diabetes Association and Diabetes Quebec, 2010). Individuals 
with diabetes access primary care at significantly higher rates and have higher rates of 
comorbidities (Greiver et al., 2014). Vasculopathies, retinopathies, neuropathies and 
nephropathies are often the long-term sequelae of DM 2 (Nield et al., 2017), meaning the 
potential for burden on healthcare systems is substantial. Managing DM 2 is lifelong and 
requires ongoing monitoring, interventions and follow-up from both the patient and healthcare 
provider (Vas et al., 2017). Current evidence establishes that individualized, provider-supported, 
patient-focused strategies are key to DM 2 treatment and management (Ferguson, Swan, 
Swaldone, 2015; Vas et al, 2017).  
 According to the Canadian Guidelines on Diabetes (DCG), pharmacological and lifestyle 
interventions remain the cornerstone of treatment (Lipscombe et al., 2018). The significance of 
nutrition in management of DM 2, for example, cannot be overstated. The DCG endorse a 
variety of nutritional eating patterns, and recommends setting nutritional goals best suited to the 
individual’s preferences (Sievenpiper, Chan, Dworatzek, Freeze, & Williams, 2018). A poor diet 
can have detrimental effects on the management of DM 2 and the prevention of its complications 
(Seligman, Jacobs, López, Tschann, & Fernandez, 2012). 
 Definitions of food insecurity (FI) are varied in the literature. FI may arise from several 
causes, although common antecedents include uncertain access to food (Essien, Shahid, & 
Berkowitz, 2016; Seligman et al., 2012; Silverman et al., 2015) resulting in inadequate 
consumption (Essien et al., 2016; Gucciardi, Vogt, DeMelo, & Stewart, 2009). In Canada, FI 
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presents a significant social and health burden. It also is closely linked to financial constraints 
and poverty. In fact, poverty is the single most important predictor of FI in Canada (Tarasuk, 
Mitchell, & Dachner, 2016). While poverty may co-occur commonly with FI, other possible 
determinants of FI remain unknown. Antecedents and other determinants are examined in the 
literature review in order to suggest possible solutions. 
  An estimated one third of individuals with diabetes experience FI (Montgomery, Lu, 
Ratliff, & Mezuk, 2017). The impact of FI on the management and control of DM 2 has been 
documented (Heerman et al., 2016). Food insecurity is an independent predictor of glycemic 
control (Patil, Craven, & Kolasa, 2017; Seligman et al., 2012) and presents a significantly 
heightened risk of dysglycemia (Essien et al., 2016). For example, individuals with DM 2 
experience an increase in hypoglycemic events, subsequent hospitalizations and also higher 
glycated hemoglobin (A1C) levels at disproportionate rates (Gucciardi, Vahabi, Norris, Del 
Monte, & Farnum, 2014). What is challenging is that the mechanisms through which FI 
influences DM 2 are unknown and not commonly identified in practice. Thus, its impact has 
remained invisible to the practitioner. Establishing management strategies for individuals with 
DM 2 without a clear understanding of the patient’s underlying struggle with FI may result in 
both ineffective and unsafe treatment plans (Essien et al., 2016). In order to enhance the 
management of DM 2 in individuals experiencing FI, it is imperative that providers understand 
how food insecurity influences the management of DM 2, and how it can be correctly identified 
in practice. 
 Primary care providers (PCP) are well-situated to address intimate issues such as FI, due 
to the trust and respect that frequently develops between patients and PCP. The chronicity of the 
professional relationship provides opportunities for the PCP to identify the patient with DM 2 
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experiencing food insecurity. Further, PCPs primarily manage the individual with DM 2, thereby 
allowing the PCP to monitor the effects and outcomes of management plans. Nurse practitioners 
(NPs) are positioned to address barriers to patient health. NPs have the ability to grasp crucial 
aspects of a patient’s perspective, motivations, issues, barriers and goals (Bartol, 2012). In 
British Columbia (B.C), NPs are trained to work with diverse populations, identify disparities in 
health outcomes, and address challenges to making, adopting and adhering to lifestyle changes 
(British Columbia College of Nursing Professionals [BCCNP], 2018a). B.C-trained NPs possess 
the competencies necessary to play a comprehensive role in healthcare, working with patients, 
families, communities and policymakers in order to improve health outcomes (BCCNP, 2018a). 
By identifying FI as a barrier to well-managed diabetes, NPs can adapt their expectations and co-
management strategies to safely meet the needs of the patient to improve dysglycemia and 
overall outcomes.  
 Addressing FI in its entirety is complex, requiring consideration of socioeconomical and 
political contexts. Certain primary care interventions, however, can offer fairly immediate relief 
to an otherwise highly complex situation. A comprehensive strategy to improve all aspects of FI 
requires a multipronged approach consisting of individual, community, policy and political 
interventions, which are beyond the scope of this paper.  
Project Purpose  
 This integrative literature review arose from graduate research on FI in diabetic 
populations and key conversations with NPs managing diabetes in primary care. Shanda Rojas, a 
primary care NP who specializes in diabetes care, highlighted a population of individuals with 
DM 2 who appeared to suffer additional difficulties in managing their diabetes. Subsequently, 
these difficulties led to additional risks and consequences to the patient’s overall health. This 
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trend was evidenced in my graduate research throughout my NP program. Regrettably, what the 
literature supported was the providers’ overall unawareness of the patient’s struggle with FI and 
thereby an inability to create an effective management plan consisting of safe, patient-centered 
pharmacological and non-pharmacological recommendations.  
 Although there are clear guidelines for the treatment and management of DM 2 (Imran, 
Agarwal, Bajaj, & Ross, 2018; Lipscombe et al., 2018; Sievenpiper et al., 2018; Sigal et al., 
2018), it is unclear how providers can identify and safely manage individuals with DM 2 
experiencing FI without understanding its impact on food consumption and other self-
management behaviors. Diabetes Canada recognizes the influence of FI on diabetes and has 
subsequently published a position statement (Diabetes Canada, 2017a). However, it does not 
provide any recommendations or guidance for the practitioner managing individuals’ FI. This 
project aims to answer the question: “How can nurse practitioners use the identification of FI in 
primary care settings to enhance the management of DM 2 among adults experiencing 
dysglycemia?”. In order to establish this aim, this integrative review examined key background 
areas through the following three questions: (1) How is food insecurity defined in the context of 
DM 2?, (2) How does food insecurity influence the management of DM 2?, and, (3) What tools 
presently exist to identify food insecurity and how can they successfully be applied to the 
Canadian healthcare context? 
 An integrative literature review methodology was used to explore each subtheme of the 
research question. For each theme, a preliminary search was conducted, and followed the 
establishment of inclusion and exclusion criteria to narrow each search strategy. Finally, a 
strategical analysis was conducted of the retrieved literature. A literature review matrix presents 
key information and findings, as well as strengths and limitations. Practice recommendations 
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elicited through an analysis and synthesis of the findings are described. Clinical implications and 
potential areas for future research are highlighted.  By outlining the impact of food insecurity on 
DM 2 and emphasizing how screening can be used to modify DM 2 management, the findings of 
this integrative review will assist future PCNPs in managing patients with DM 2 experiencing FI.  
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Chapter 2 
Background 
 Food insecurity (FI) can significantly affect the management of type 2 diabetes (DM 2). 
Poorly managed diabetes is a significant problem in healthcare and leads to several long-term 
consequences. PCP can help mediate some of the burden and risk associated with FI to improve 
the management of DM 2. In this chapter, the incidence and prevalence of DM 2 in Canada is 
reviewed, followed by the pathophysiology, assessment, diagnosis of DM 2, along with its 
complications. Following this, the pharmacological and non-pharmacological clinical guidelines 
from Diabetes Canada are discussed, proceeded by a short discussion on Pharmacare and the 
coverage of antihyperglycemic medications. This is followed by a discussion on FI, its influence 
on health and the management of DM 2, along with barriers to identifying FI in practice. Further, 
Maslow’s Theory of Motivation (MTM) is discussed along with its relevance to patient 
behaviors, motivation and managing DM 2 in individuals with FI. Lastly, the role of the NP as a 
PCP is discussed, and their capacity to identify and mediate the risks associated with FI in DM 2.  
Overview of Type 2 Diabetes Mellitus  
 Diabetes Mellitus 2, or Type 2 Diabetes (DM 2) is a chronic metabolic disease affecting 
the entire body. Traditional clinical indicators of DM 2 include: (a) insulin resistance in the liver, 
muscle and adipose tissue; (b) decreased insulin production in the pancreas secondary to beta cell 
dysfunction and loss; which (c) results in inappropriate metabolism of glucose throughout the 
body (Brashers, Jones & Huether, 2014b). Recently, multiple organs and hormones have been 
implicated in the development of DM 2 (DeFronzo, 2009). And, the onset of DM 2, historically 
between 40-70 years, has shifted to much younger populations in recent years (Brashers, Jones & 
Huether, 2014b).  
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 Incidence and prevalence. 
 Over the last three decades, the incidence of DM 2 has doubled across all age groups 
(Brashers, Jones & Huether, 2014). DM 2 accounts for 90-95% of incidence rates of diabetes 
(Canada Institution for Health Information, 2015; Centre for Disease Control and Prevention, 
2017; Diabetes Canada, 2017; International Diabetes Federation, 2014 & PHAC, 2011). In 2016, 
the estimated incidence of DM 2 in Canada was approximately 6.3%-6.65%, and occurred more 
frequently in males than females (Statistics Canada, 2016).  
 Despite this uniform increase in incidence, some age groups have experienced a sharp 
rise in prevalence. Between 1999-2009, the prevalence of DM 2 doubled in individuals aged 35-
49 years (Public Health Agency of Canada [PHAC], 2011), meaning that DM 2 is becoming 
more prevalent in younger age groups. In 2015, the estimated prevalence of DM 2 in Canada was 
between 8.4-8.8% (Diabetes Canada, 2017a). In 2017, the prevalence of DM 2 in British 
Columbia (B.C.) was 9.5% (Diabetes Canada, 2017b). A steady increase in prevalence is 
projected for Canada (Diabetes Canada, 2017b) to an estimated 10.8% by 2020 (Canadian 
Diabetes Association and Diabetes Quebec, 2010). It is estimated that treating DM 2, its 
complications, and associated productivity loss will cost greater than $19 billion a year by 2020 
(Canadian Diabetes Association, 2009).  
 The incidence and prevalence of DM 2 varies by age, gender, income, ethnicity and 
geographical region (PHAC, 2011; Shah, 2013). The incidence and prevalence of DM 2 is likely 
underrepresented as a third of cases are estimated to be undiagnosed (Diabetes Canada, 2017a), 
and up to a third of people with known diabetes do not feel comfortable disclosing their 
diagnosis (Canadian Diabetes Association, 2015).  
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 Pathophysiology. 
 DM 2 involves complex interactions between the environment and individual genetics, 
resulting in dysfunction of multiple organs and hormones which cause: (a) insulin resistance 
secondary to liver (DeFronzo, 2009), muscle cell (Brasher, Jones & Huether, 2014b) and adipose 
tissue dysfunction (Yazıcı & Sezer, 2017); (b) reduced insulin production secondary to beta cell 
dysfunction and loss in the pancreas (Brasher, Jones & Huether, 2014b); (c) dysregulated 
signalling of insulin secretion by the incretins in the gastrointestinal tract (Tasyurek, Altunbas, 
Balci, & Sanlioglu, 2014) and brain (Kleinridders, Ferris, Cai, & Kahn, 2014); (d) dysregulation 
of blood glucose levels by the kidneys (Brasher, Jones & Huether, 2014b); (e) dysregulated 
signalling of glucose production by adipose tissue (Stinkens, Goossens, Jocken, & Blaak, 2015), 
dysregulated signalling of incretins in the gastrointestinal tract (Tasyurek, Altunbas, Balci, & 
Sanlioglu, 2014) and the pancreas (Brasher, Jones & Huether, 2014b); (f); dysregulated glucose 
production in the liver (Petersen, Vatner, & Shulman, 2017); (g) dysregulated glucose 
homeostasis from disrupted glucose sensing in brain (Brashers, Jones & Huether, 2014a, p.734); 
and (h) dysregulated leptin (Meek & Morton, 2016) and ghrelin secretion (Chabot, Caron, 
Laplante, & St-Pierre, 2014). 
 Assessment, diagnosis and monitoring. 
 Diabetes Canada (DC) provides national guidelines for the assessment, diagnosis and 
management of individuals with DM 2. According to the DC guidelines, diabetes is diagnosed 
when two of the following criteria are met: (a) The glycated hemoglobin (A1C) is greater than 
6.5 %, (b) a fasting plasma glucose is greater than 7mmol/L, (c) a random plasma glucose is 
greater than 11 mmol/L, or (d) a 2-hour plasma glucose with a 75 gram oral glucose tolerance 
test is greater than 11.1 mmol/L (Punthakee, Goldenberg, & Katz, 2018). Only one positive test 
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is required for the individual presenting with symptomatic hyperglycemia (Punthakee et al., 
2018). 
Glycated hemoglobin (A1C). 
  The A1C is a reliable surrogate marker of glycemic control, representing the mean 
plasma glucose for the previous 8-12 weeks (Berard et al., 2018). Chronically elevated A1C’s 
are associated with an increased risk of diabetic complications, such as retinopathies, 
nephropathies, neuropathies and cardiovascular disease (Seligman & Schillinger, 2010), and 
therefore the guidelines recommend measuring the A1C every 3 months until target A1C levels 
are reached (Berard et al., 2018). The target A1C for most individuals is less than 7%, and when 
clinically indicated, select individuals target A1C levels between 7.1 to 8.5%, or greater than 
8.5% (Imran et al., 2018). While A1C is a reliable mean, it does not capture individual episodes 
of hyperglycemia and hypoglycemia. 
 Self monitoring of blood glucose (SMBG). 
  Using a glucose meter to SMBG provides isolated blood glucose values, and therefore 
can accurately identify individual episodes of dysglycemia and provide immediate information 
on the effects of pharmacological and non-pharmacological interventions (Berard et al., 2018). 
The DC guidelines recommend an individualized approach to SMBG considerate of diabetic 
type, pharmacological regimen, treatment changes, illnesses, hypoglycemia awareness or risks 
and occupational requirements (Berard et al., 2018). SMBG is most successful at promoting 
behavior change, improving blood glucose levels and preventing hypoglycemia when paired with 
structured education (Berard et al., 2018).  
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 Complications. 
 Several complications are associated with diabetes: (a) macrovascular complications 
including hypertension, coronary artery disease, peripheral vascular disease and cerebral vascular 
disease; (b) microvascular complications including retinopathies, nephropathies, peripheral 
neuropathies and gastroparesis; (c) infections; and (d) amputations (Brashers, Jones & Huether, 
2014a). Diabetes Canada (2017b) estimates that 30% of cerebral vascular events, 40% of 
myocardial infarctions, 50% of end-stage renal failure and 70% of non-traumatic amputations are 
attributable to diabetes (p.3). Optimal diabetes management, including maintaining target A1C 
levels, is key in the prevention of complications. 
 Management. 
 The Canadian diabetes guidelines for the treatment and management of DM 2 
recommend a multifaceted pharmacological and non-pharmacological approach that: (a) 
manages and prevents hyperglycemia and its associated symptoms, and (b) decreases the risks of 
microvascular and macrovascular complications (Lipscombe et al., 2018). Even with optimal 
management and strict adherence to successful treatment strategies, DM 2 usually progresses 
over time resulting in increased use of non-pharmacological and pharmacological interventions 
(Lipscombe et al., 2018). 
 Non-pharmacological management.  
 Non-pharmacological strategies are the first-line treatment in the management of DM 2, 
and recommended as monotherapy for the first 3 to 6 months when an individual’s A1C is less 
than 8.5% at diagnosis and they present with no signs of metabolic decompensation (Lipscombe 
et al., 2018). Some individuals achieve target A1C levels using lifestyle interventions only.  
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 DM 2 Self-management education (SME) and support (SMS).  
 DM 2 SME and SMS use patient-provider collaboration and clinical support that focuses 
on educating, motivating and empowering individuals to problem-solve and use goal setting 
strategies to modify behaviors and self-monitor their chronic disease (Sherifali, Rabi, et al., 
2018). SME and SMS improves glycemic control, self-efficacy, SMBG and healthy eating while 
decreasing diabetes-related distress and complications (Sherifali, Rabi, et al., 2018, p. S36). 
 Weight management. 
 An increased body-mass index (BMI) and abdominal adiposity impairs glycemic control, 
contributes to hypertension and dyslipidemia, and increases the risk of diabetic complications 
(Wharton, Pedersen, Lau, & Sharma, 2018). An estimated 80 to 90% of individuals with DM 2 
are overweight (Wharton et al., 2018), but substantial improvements in insulin sensitivity, 
cellular glucose uptake, and hepatic glucose regulation are noted with as little as 5% to 10% loss 
of initial body weight (Wharton et al., 2018). The DC guidelines recommend a combination of 
physical activity and nutritional interventions to target a minimum weight loss of 5 to 10% in 
individuals who are overweight (Wharton et al., 2018). Addressing barriers to weight loss 
including depression, food behaviors or physical impediments to exercise is key to creating a 
successful weight loss strategy (Wharton et al., 2018). 
 Nutrition. 
 Healthy dietary strategies can significantly lower an A1C approximately 1 to 2% 
(Sievenpiper et al., 2018). The DC guidelines endorses healthy food choices from 4 major food 
groups, based on Eating Well with Canada’s Food Guide: (1) fruits and vegetables, (2) grains, 
(3) milk and alternatives, and (4) meat and alternatives (Health Canada, 2007; Sievenpiper et al., 
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2018). Meals should be a mix of macronutrients and distribution should be flexible to allow for 
individual preferences (Sievenpiper et al., 2018) 
 Moderate and consistent intake of carbohydrates (CHO) comprised of varied, low 
glycemic, high fiber and whole food options are key in lowering A1C levels, controlling 
dysglycemia, managing weight, controlling lipids, improving clinical and metabolic outcomes 
and preventing micro and macrovascular complications such as cardiovascular events 
(Sievenpiper, Chan, Dworatzek, Freeze, & Williams, 2018, p. S64). Fruits, vegetables, legumes 
and whole grains are preferred choices (Sievenpiper et al., 2018). Maintaining CHO at 45% to 
60% of daily intake appears to demonstrate the greatest benefit in glycemic control and the 
prevention of diabetic complications (Sievenpiper et al., 2018). Added sugars, in particular high-
fructose corn syrup, sucrose and fructose at greater than 10% of daily intake, should be avoided 
as much as possible due to their impact on fasting blood glucose levels and triglycerides 
(Sievenpiper et al., 2018). 
 Preferred selections exist for several non-CHO macronutrients: Unsaturated fat is 
recommended over saturated fat to reduce risk of cardiovascular events (Sievenpiper et al., 
2018); Vegetable protein is recommended over animal protein, as vegetable protein substitutions 
have demonstrated reduced A1C levels, fasting plasma glucose (FPG) and improved fasting 
insulin (Viguiliouk et al., 2015). 
 Other dietary strategies include: (a) reducing caloric intake and increasing daily protein 
intake to target weight loss and increase satiety (Sievenpiper et al., 2018); (b) carbohydrate 
counting to regulate the timing, constancy and quantity of CHO (Sievenpiper et al., 2018); (c) 
limiting sugar-sweetened foods and beverages (SSFB) to less than 10% of total daily intake to 
maintain weight and glycemic control (Sievenpiper et al., 2018); (d) minimizing refined sugars 
13 
 
       
and fast foods due to dysglycemia, weight gain and diabetic complications (Sievenpiper et al., 
2018); and (e) regular consumption of legumes, beans and lentils to lower A1C, promote 
glycemic control and reduce various serum markers associated with cardiovascular disease 
(Sievenpiper et al., 2018). Dietary patterns most closely aligning with these recommendations 
include the Mediterranean diet, DASH diet and a vegetarian diet (Sievenpiper et al., 2018). 
Consideration to values, preferences and goals helps a person adhere to dietary strategies over 
the long term (Sievenpiper et al., 2018).  
  Research examining the effects of intermittent fasting and energy restriction on weight 
loss has become prevalent in the general population, but its effects in on glycemic control is 
limited. In a recent pilot trial, Carter, Clifton and Keogh (2016) compared the effects of 
intermittent severe energy restriction versus a moderate continuous calorie restricted weight loss 
diet and found glycemic control and weight reduction were similar (Carter, Clifton, & Keogh, 
2016). However, the individuals who severely restricted their intake required significant 
medication adjustments or discontinuation, particularly with insulin and sulfonylureas, to prevent 
hypoglycemic events (Carter et al., 2016). De-prescribed sulfonylureas produced inconsistent 
results, with some participants experiencing rebound hyperglycemia (Carter et al., 2016). 
Diabetes SMS and SME should work to identify and mediate barriers to healthy food behaviors 
(Sievenpiper et al., 2018) for individuals experiencing involuntary restriction of nutritional 
intake. 
 Physical activity. 
 Aerobic exercise, i.e. continuous movement of large muscle groups for a minimum of 10 
minutes (Sigal et al., 2018, p. S55) and resistance training, i.e. repetitive weighted movements to 
increase muscle strength or mass (Sigal et al., 2018, p. 55) assist in the regulation of blood 
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glucose, insulin resistance, lipid regulation, blood pressure, weight loss and reduction of 
macrovascular complications (Sigal et al., 2018). The DC guidelines recommend at least 150 
minutes of aerobic activity a week, a minimum of 2 days per week of resistance exercise (Sigal 
et al., 2018), and physical movement every 20 to 30 minutes (Sigal et al., 2018).  
 Pharmacological management. 
 The guidelines recommend that pharmacological management be commenced when non-
pharmacological options are insufficient in reducing the A1C to target levels within the first 3 to 
6 months, or if the individual’s A1C is greater than 8.5% at diagnosis (Lipscombe et al., 2018). 
Metformin is preferred as first line treatment in the pharmacological management of DM 2 
because it is safe, inexpensive, effective at reducing A1Cs, and is associated with a low risk of 
hypoglycemia, weight gain and adverse effects (Lipscombe et al., 2018). Metformin is a 
biguanide that decreases hepatic glucose production and improves hepatic insulin sensitivity by 
activating AMP-activated protein kinase (Lipscombe et al., 2018). However, when symptomatic 
hyperglycemia or signs of metabolic decompensation such as weight loss or ketosis are present at 
diagnosis, insulin should be initiated, irrespective of A1C (Lipscombe et al., 2018).  
 Second line agents are added to metformin when: (a) initial A1C or symptomatology at 
diagnosis indicate the need for more aggressive therapy or (b) the A1C remains above the 
patient-specific target after 3-6 months of monotherapy (Lipscombe et al., 2018). The DC 
guidelines recommend adding an agent every 3 to 6 months until target A1C levels are reached 
(Lipscombe et al., 2018). Traditionally, insulins and insulin secretagogues, such as sulfonylureas, 
have been first-line treatment for add-on therapy. However, the risks of hypoglycemia and 
weight gain are greatest in these classes and should not be the first choice in populations at 
increased risk of hypoglycemia (Lipscombe et al., 2018). 
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 Over the last decade, newer pharmacological options have become available, meaning 
there is greater flexibility in individualizing treatment plans to the needs of a patient (Diabetes 
Canada, 2017b).  Further, these newer agents have fewer side effects (Diabetes Canada, 2017b), 
provide superior glucose control and A1C stability (Diabetes Canada, 2017b), and have a 
superior safety profile (Lipscombe et al., 2018). Approach and selection of antihyperglycemic 
therapy should consider clinical presentation, patient risk factors, values and preferences in order 
to provide a treatment regimen most appropriate for the individual (Lipscombe et al., 2018). Key 
to this process includes understanding the individual’s disposition, their social needs and their 
ability to afford or observe a particular pharmacological regimen (Lipscombe et al., 2018). 
Treatment should be promptly modified when adherence issues are present (Lipscombe et al., 
2018).  
 The DC guidelines recommend dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like 
peptide-1 (GLP-1) receptor agonists or sodium-glucose linked transporter-2 (SGLT-2) inhibitors 
over traditional agents due to their negligible risk of hypoglycemia and weight gain, and non-
inferior A1C-lowering capacity (Lipscombe et al., 2018). Additionally, select GLP-1 agonists 
and SGLT-2 inhibitors are associated with reduced microvascular and cardiovascular 
complications in individuals with identified cardiovascular risks (Lipscombe et al., 2018). 
 Insulins. 
 Insulins are an exogenous source of insulin, and when injected, stimulate insulin cell 
receptors to normalize the metabolism of carbohydrate, fat, and protein (Lipscombe et al., 2018) 
through cellular uptake. Insulins offer the greatest potential for a reduction in A1C; however, all 
pose some risk of hypoglycemia when food intake is inconsistent or reduced (Lipscombe et al., 
2018).  
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 When commencing insulins, long-acting or intermediate-acting insulins are generally 
commenced first, and given at night to offer basal or glycemic control and improve fasting 
morning blood sugars (Lipscombe et al., 2018). Long-acting insulins are preferred over 
intermediate-acting insulins because they do not have a peak effect, i.e. there is a decreased risk 
of symptomatic or nocturnal hypoglycemia (Lipscombe et al., 2018). When bolus or mealtime 
insulin is commenced, sulfonylureas should be de-prescribed due to concomitant risks of 
hypoglycemia (Lipscombe et al., 2018). Rapid acting insulins pose less risk of postprandial 
hypoglycemia than short-acting insulins and should be preferentially prescribed wherever 
affordable and appropriate (Lipscombe et al., 2018). Concomitant prescribing of other 
antihyperglycemics is encouraged: Regimens consisting of combination insulin and non-insulin 
agents reduce the level of weight gain and risks of hypoglycemia associated with insulin only 
regimens (Lipscombe et al., 2018). 
 Sulfonylureas. 
 Sulfonylureas are an insulin secretagogue which acts on β-cell sulfonylurea receptors and 
stimulates the release of endogenous insulin (Lipscombe et al., 2018). Sulfonylurea work fairly 
rapidly and do not work in a glucose-dependent fashion, meaning they can pose a moderate risk 
of hypoglycemia (Lipscombe et al., 2018) especially with reduced glucose intake. Certain 
sulfonylureas are more problematic over others (Lipscombe et al., 2018). Glyburide offers the 
greatest risk of hypoglycemia; however, prescribing habits are likely influenced by Pharmacare 
coverage, as glyburide remains the only unrestricted sulfonylurea in the public formulary 
(Government of Canada, 2018b). Gliclazide poses the least risk of hypoglycemia, cardiovascular 
events and overall mortality and is the preferred choice of sulfonylurea (Lipscombe et al., 2018). 
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Weight gain is a common side effect due to their insulin-releasing properties (Lipscombe et al., 
2018).  
 Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor 
 agonists. 
 Incretins exert their effect only when glucose is ingested, meaning they possess a near 
negligible risk of hypoglycemia. Both DPP-4 inhibitors and GLP-1 receptor agonists increase the 
signalling and release of insulin when glucose is sensed in the gastro-intestinal tract. They also 
slow gastric emptying and inhibit glucagon release (Lipscombe et al., 2018). All GLP-1 receptor 
agonists are associated with weight loss; however, additional weight loss is seen at higher doses 
of liraglutide (Wharton et al., 2018). Liraglutide and semaglutide are the only cardioprotective 
GLP-1 receptor agonists (Lipscombe et al., 2018). Pharmacological complications are rare, 
however, gastrointestinal side effects such as nausea, or diarrhea, are common especially in 
GLP-1 receptor agonists (Lipscombe et al., 2018).  
 Sodium-glucose linked transporter-2 (SGLT-2) inhibitors. 
 SGLT-2 inhibitors block the sodium-dependent glucose cotransporters responsible for 
renal glucose reabsorption back into the bloodstream (Lipscombe et al., 2018). The net action is 
increased glucosuria and decreased blood-glucose levels (Lipscombe et al., 2018). SGLT-2 
inhibitors possess nearly a negligible risk of hypoglycemia, and a potential reduction of 2 to 3 kg 
of body weight (Lipscombe et al., 2018). This class’ diuretic-like properties offer an additional 
benefit of a reduction in systolic blood pressure, and a reduced or slowed progression of 
nephropathy (Lipscombe et al., 2018). In individuals with known cardiovascular disease, they are 
associated with: (a) reduced heart failure; (b) with empagliflozin and canagliflozin only, a 
reduction in major adverse cardiovascular events; and (c) with empagliflozin only, a decrease in 
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cardiovascular death (Lipscombe et al., 2018). There is a significant increase in the occurrence of 
genital mycotic and urinary tract infections, hypotension and volume depletion (Lipscombe et 
al., 2018). There are some adverse outcomes attributed to canagliflozin in particular, which 
include increased fractures, lower extremity amputations and acute renal injury (Lipscombe et 
al., 2018). 
 Thiazolidinediones (TZDs).  
 TZDs target insulin resistance by increasing peripheral tissue and hepatic insulin 
sensitivity in a variety of cell receptors (Lipscombe et al., 2018). Subsequently they are 
associated with weight gain, but a negligible risk of hypoglycemia (Lipscombe et al., 2018). The 
use of TZDs has substantially diminished over the past decade due to an increased incidence of 
edema, heart failure, significant risk of fractures, and possible risk of myocardial infarctions with 
rosiglitazone (Lipscombe et al., 2018). Pioglitazone remains the only TZD available in B.C. 
(Government of British Columbia, 2018b). 
 Alpha glucosidase inhibitors (acarbose). 
 Acarbose works by preventing pancreatic α-amylase and intestinal α-glucosidase from 
breaking down and absorbing carbohydrates (Lipscombe et al., 2018), which reduces and delays 
the absorption of glucose into the bloodstream. Gastrointestinal side effects such as bloating, gas 
and diarrhea are common and require three times a day dosing (Lipscombe et al., 2018). B.C. is 
the only province where Acarbose is de-listed and no longer available (Diabetes Canada, 2017b).  
 Orlistat. 
 Orlistat is used as a weight loss agent by preventing lipase from breaking down fats.  
By assisting with weight loss, Orlistat improves glycemic control and subsequently results in 
dose reduction of antihyperglycemic medications (Wharton et al., 2018). It is associated with 
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gastrointestinal side effects such as nausea and diarrhea. However, due to its mechanism of 
action, it produces a negligible risk of hypoglycemia (Lipscombe et al., 2018). 
Pharmacare 
 Pharmacare is British Columbia’s public drug insurance program. Pharmacare is 
comprised of several publicly-funded drug plans for whom select individuals are eligible 
depending on each plan’s criteria (Government of British Columbia, 2018a). Select populations 
have 100% of the drugs in the Pharmacare’s formulary covered. This includes permanent 
residents of licensed residential care facilities (Plan B), recipients of B.C. income assistance 
(Plan C) and First Nations (Plan W). Fair Pharmacare is B.C’ s only public drug plan eligible to 
all B.C. residents with active Medical Services Plan of B.C. (MSP). Fair Pharmacare is 
dependent upon household income (Government of British Columbia, 2018a). An annual 
minimum deductible must be reached before 70% of the drug cost will be covered, and a family 
maximum deductible must be reached before drugs are 100% covered (Government of British 
Columbia, 2018a). While Plan C offers 100% coverage to British Columbians living below the 
poverty line and who are receiving income assistance, many Canadians not receiving income 
assistance live below the poverty line and must spend money before they receive assistance from 
Pharmacare. For example, a family of four in B.C. living on wages equivalent to the average 
poverty line in B.C1, must spend approximately $950.00-$1100.00 to reach their deductible and 
$1350-1500.00 to have medications fully covered (Government of British Columbia, 2018c).  
 While eligibility and deductibles vary from person to person, the list of 
antihyperglycemics available through Pharmacare’s formulary is the same across all plans: 
                                                          
1 Calculated using Statistics Canada’s (2018a) estimated Market Basket Measure (MBM) for a family of four living 
in B.C. ($37,153- $39,951 depending on rural versus urban living). Canada has recently structured and developed an 
official poverty line called the Market Basket Measure (MBM) and is currently being validated throughout Canada 
(Statistics Canada, 2018b).  
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Metformin, glyburide and select short and intermediate-acting insulins are listed restriction-free 
on the formulary (Government of Canada, 2018b). Rapid-acting insulins are available to 
individuals capable of paying the cost difference between short and rapid-acting insulins 
(Government of Canada, 2018b).  
 Presently, B.C. remains the only province where none of the newer more expensive 
antihyperglycemic medications such as SGLT-2 inhibitors, GLP-1 agonists, or DPP-4 inhibitors 
are listed on the public formulary without Special Authority (Diabetes Canada, 2017b). Further, 
Special Authority (SA) coverage only exists for linagliptin and saxagliptin2 when maximum 
tolerated doses of metformin and sulfonylureas have been tried and insulin NPH was found to be 
ineffective or inappropriate (Government of British Columbia, 2018d). Subsequently primary 
care providers have had to find creative strategies to provide the pharmacotherapy most suitable 
for the patient while working in conjunction with Pharmacare and patient income.  
 Therefore, individuals with financial constraints and without additional private coverage 
are more likely to rely on Pharmacare-covered medications due to the prohibitive costs of newer 
medications (Diabetes Canada, 2017b). They may experience significant restrictions in 
pharmacological options, subsequently resulting in greater difficulty and risks in managing his or 
her DM 2.  Lastly, Pharmacare funds blood glucose strips solely based on pharmacological 
regimen (Government of British Columbia, 2018b), which presents a challenge to individuals 
who cannot afford additional strips, possess additional challenges in monitoring their blood 
glucose, and are at increased risk for dysglycemia.  Under special circumstances, specific 
healthcare providers may apply for additional strips if the patient is not on insulin and: (a) is not 
meeting target glycemic levels after 3 months, (b) has present or concomitant illnesses which 
                                                          
2 Includes combinations with metformin 
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interfere with glycemic control, (c) is undergoing medication changes which affect glycemic 
control, (d) has a vocation where dysglycemia presents a significant safety risk, or (e) the patient 
is a gestational diabetic (Government of Canada, 2019). If SA is approved, individuals are 
eligible for 100 extra strips annually. 
Overview of Food Insecurity (FI) 
 FI exists when individuals have uncertain access to adequate amounts of nutritious food 
(Essien et al., 2016; Montgomery et al., 2017; Seligman et al., 2012) It is a worldwide epidemic, 
reaching all corners of society (WHO, 2018). Several Canadian studies have identified poverty 
and financial constraints as antecedents to FI in Canada (Beryl Pilkington et al., 2010; Chan, 
DeMelo, Gingras, & Gucciardi, 2015; Li, Dachner, & Tarasuk, 2016; Tarasuk et al., 2016; 
Thomas, Fitzpatrick, Sidani, & Gucciardi, 2018). In Canada, the prevalence and severity of FI 
does not exist exclusively among the impoverished (Patil et al., 2017): FI increases as income 
decreases in a near linear fashion (Li et al., 2016). The “Research to Identify Policy Options to 
Reduce Food Insecurity” (PROOF) is funded by the federal Canadian government to monitor the 
prevalence of income-associated food insecurity (IAFI) in Canada (2018), and defined FI as “the 
inadequate or insecure access to adequate food due to financial constraints (Tarasuk et al., 2016, 
p. 6)”. Since 2005, FI has continued to increase in Canada and in British Columbia (Li et al., 
2016; Tarasuk et al., 2016). Approximately 1 in 8 households in Canada are classified as “food 
insecure”, which accounts for approximately 4 million Canadians (Tarasuk, Mitchell & Dachner, 
2014); In B.C. approximately 1 in 10 households, or half a million British Columbians, are food 
insecure (Li et al., 2016). It remains unclear, however, what the prevalence rates and causes of 
other forms of FI in Canada are, but it is speculated to encompass significantly more of the 
Canadian population. Examples of other documented causes of FI include physical barriers to 
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access, geography, inability to safely prepare food, labile food prices, and variability to food 
crops (Strickhouser et al., 2014). Further, some populations appear to be at greater risk than the 
general population, including women, single parents, elderly and immigrants (Gucciardi et al., 
2014). 
 FI affects health, though the relationship is complex and not necessarily causational 
(Berkowitz & Fabreau, 2015). FI impairs the prevention, treatment and management of several 
chronic diseases (Tarasuk et al., 2015), Though the mechanisms are not entirely understood, FI is 
independently associated with increased healthcare utilization costs, and both poorer physical 
and mental health (Tarasuk et al., 2015). FI interferes with self-care and functional health, and 
overall worse chronic disease outcomes (Tarasuk et al., 2015).  
Food insecurity in type 2 diabetes. 
 The prevalence of food insecurity (FI) among Canadians with DM 2 occurs at 
disproportionate rates (Chan et al., 2015; Galesloot, McIntyre, Fenton, & Tyminski, 2012; 
Gucciardi et al., 2009). FI in individuals with DM 2 is associated with inferior glycemic control, 
and worsening A1C values (Ippolito et al., 2016). There is evidence that FI interferes with DM 2 
self-management strategies (Ippolito et al., 2016), but the mechanism is not yet understood. 
Diabetic complications also occur at significantly higher rates (Montgomery et al., 2017; 
Seligman et al., 2012). There are no best-practice strategies for the management of individuals 
with DM 2 experiencing FI (Thomas et al., 2018), therefore the interface between FI and 
successful management of DM 2 remains unclear and is at the epicentre of this integrative 
review. Thus, an integrative review exploring how FI interferes with the management of DM 2 is 
necessary before an effective management approach can be established for the food-insecure 
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diabetic. Additionally, further exploration of the literature is required to examine how FI may 
best be identified in primary care. 
Identifying food insecurity. 
 Presently, there is no standardized process or method for identifying all forms and 
measures of FI (Jones, Ngure, Pelto, & Young, 2013), nor is there a specific method for 
identifying FI amongst individuals with DM 2 (Thomas et al., 2018). Identifying food insecurity 
can be challenging for several reasons. Firstly, people who are food insecure do not represent a 
homogenous group (Strickhouser, Wright, & Donley, 2014). For example, based on Canadian 
data that monitors IAFI, 65% of the FIFC in British Columbia are employed (Li et al., 2016), 
16% live on social assistance, 12 % are seniors relying on seniors’ income, and the remaining 
rely on Employment Insurance, workers compensation or other sources as their main source of 
income (Li et al., 2016). Unattached individuals and individuals with no children represent over 
40% of IAFI in B.C., but families with children and women have higher rates of FI overall (Li et 
al., 2016). Caucasians, Asians, and other ethnic groups in B.C. share similar rates of FI, but 
nearly a third of B.C.’s IAFI self-identify as Aboriginal (Li et al., 2016).  
 Secondly, FI screening is not routinely completed or well integrated into practice. There 
is no systematic evidence-based method for determining how FI screening should unfold in 
healthcare settings. In a recent systematic review examining the validity, acceptability and 
implementation of FI screening in healthcare, De Marchis, Torres, Fichtenberg and Gottlieb 
(2019) found that there is limited direction in healthcare settings on how to implement FI 
screening in practice. 
 Thirdly, while De Marchis et al., (2019) identified several FI screening tools validated in 
US healthcare settings, it is unclear whether Canadian providers have access to peer-reviewed, 
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standardized and validated tools to identify FI in the Canadian healthcare context. Furthermore, 
it is unclear how FI is defined in each screening tool: in a recent systematic review examining 
available tools for measuring FI, Ashby, Kleve, McKechnie and Palermo, (2016) found that most 
current tools were subjective in nature, had a limited scope in identifying FI and primarily 
identified access issues in FI. Identifying a standardized FI screening tool validated for use in 
Canadian healthcare is an essential aspect of this integrative review.  
 In Canada, IAFI has been routinely monitored through research grants by Policy Options 
to Reduce Food Insecurity (PROOF, 2018b), using a validated and standardized measurement 
called the Household Food Security Survey Module (HFSSM). The HFSSM is part of the 
Canadian Community Health Survey (CCHS), which Statistics Canada uses to collect health 
information on a sample of Canadians every two years (PROOF, 2018b). While the HFSSM was 
originally developed and used in the Unites States (US) by the US Department of Agriculture, it 
was later adapted and approved by Health Canada for its use in Canada (Health Canada Office of 
Nutrition Policy and Promotion 2007). It remains unclear if the Canadian-specific HFSSM has 
been validated for use in healthcare settings to identify FI at the individual level or whether it has 
been validated to identify other forms of FI. 
 Benefits of screening food insecurity in practice. 
 Clinicians have questioned whether routine screening for FI in clinical settings should be 
completed (Berkowitz & Fabreau, 2015). There is little evidence that screening and identifying 
food insecurity improves health outcomes (Berkowitz & Fabreau, 2015), but screening is 
supported by some clinical experts when it results in adjustments to clinical management and 
improves safety (Berkowitz & Fabreau, 2015). For example, Berkowitz and Fabreau (2015) 
indicate that identifying FI in healthcare is clinically significant for individuals with DM 2, 
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because it can directly support important pharmacological and clinical decisions when food 
behaviors may be causing dysglycemia. In this circumstance, identifying FI assists the provider 
with specific and appropriate SME and SMS, including self-titration of medication during low 
food periods (Berkowitz & Fabreau, 2015), or de-prescribing specific medications which pose a 
specific risk to the individual. 
Maslow’s Theory of Motivation (MTM) 
 It is important to consider an individual’s capacity to be motivated to make health 
behavior changes and self-actualize in the face of long-standing FI. Maslow’s Theory of 
Motivation (MTM) was developed in the 1940’s, and describes motivation for human behavior 
(Maslow, 1943). While our understanding of human motivation and behavior has evolved over 
time, MTM continues to be influential in practice and offers insight to human behaviors with 
respect to health behaviors. Maslow’s theory (1943) is based on 5 basic tenets: (1) We have five 
sets of basic needs, namely physiological, safety, love, esteem and self-actualization. Humans 
are motivated by a desire to satisfy these needs (Maslow, 1943, p. 394); (2) These 5 needs exist 
in a hierarchical, but not mutually exclusive manner: when the more basic needs are unmet, they 
dominate the conscious mind, while other ‘higher’ needs become irrelevant, minimized and 
sequestered from awareness (Maslow, 1943, p. 394). Only when a more basic need is adequately 
satisfied, can a higher need begin to dominate an individual’s consciousness (Maslow, 1943, p. 
394); (3) Any real or perceived threat to the security of these needs is perceived as a 
psychological threat (Maslow, 1943, p. 394); (4) these threats generate emergency or 
compensatory reactions in behavior (Maslow, 1943, p. 394); (5) some motivators of human 
behavior are not yet or cannot be explained by this model (Maslow, 1943, p. 394). 
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 MTM postulates that food is one of the most basic physiological human needs (Maslow, 
1943); Therefore, MTM may provide further insight into why individuals with FI may struggle 
with managing DM 2. Further, MTM may highlight how recommending self-management 
approaches in DM 2 when FI is present may be inadequate and even inappropriate. Lastly, MTM 
may highlight the enhanced value of individualized, FI-informed management strategies when 
patients are significantly limited in their capacity to self-manage their DM 2. 
The Nurse Practitioner (NP)  
 In Canada, NPs are graduate level, master degree prepared advanced practice nurses 
(BCCNP, 2018a) working within a legislated scope of practice under the B.C. Health Professions 
Act (RSBC, 1996), and regulated by the British Columbia College of Nursing Professionals 
(BCCNP, 2018a). The NP scope includes diagnosing, ordering and interpreting diagnostic tests, 
prescribing pharmaceuticals, and providing holistic health management, health promotion and 
disease prevention strategies (BCCNP, 2018a).  
 Nurse Practitioners (NPs) in primary care. 
 NPs are trained as family nurse practitioner in B.C. As of 2018, over 500 NPs are 
registered in B.C, and approximately 60% work in primary care (Nurse and Nurse Practitioners 
of British Columbia [NNPBC], 2018) offering unique strategies in addressing barriers to patient 
health. Fundamental to this capacity is the NP’s ability to grasp crucial aspects of a patient’s 
perspective, motivations, issues, barriers and goals in order to effectively manage health (Bartol, 
2012). NPs are specifically educated to identify difficulties in making, adopting and adhering to 
lifestyle changes and can partner with patients, families, communities and organizations to 
implement useful techniques (BCCNP, 2018a).  
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 A recent evaluation of the integration of NPs into the B.C. healthcare system revealed 
that the majority of NPs are providing direct patient care in office settings for chronic conditions, 
including diabetes (Sangster-Gormley et al., 2015). Many of these patients have complex health 
conditions and several social issues (Sangster-Gormley et al., 2015). The review of data from 
B.C.’s NP demonstrate NPs are spending the majority of time managing these chronic health 
conditions by screening, providing pharmacotherapy, engaging in health education, and 
integrating preventive health approaches (Sangster-Gormley et al., 2015).  
 NPs are seen as an added benefit because they increase access to care, are effective at 
enacting behavior change, use a collaborative, comprehensive, team-based and patient-centered 
approach and deliver high levels of patient satisfaction (Sangster-Gormley et al., 2015). In B.C., 
NPs are delivering a high-quality care with patient outcomes similar to that of general 
practitioners (Prodan-Bhalla & Scott, 2016). The NP practice approach could facilitate the 
implementation of formal FI screening and modified patient-centered treatment strategies in 
practice. This integrative literature review will contribute to the growing interest in NPs and their 
unique contributions as PCPs by exploring how NPs can identify FI in the PC setting to enhance 
the management of individuals with DM 2 experiencing FI. 
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Chapter 3 
Methods 
 As part of my prior scholarly work, an extensive initial literature search was executed to 
examine the best evidence and recommendations for the dietetic management of type 2 diabetes 
(DM 2). Several practice guidelines, systematic reviews and meta analyses were found 
describing nutritional recommendations for the management for DM 2. A follow-up literature 
search examined how food insecurity (FI) influenced a person’s capacity to follow evidenced-
based dietary strategies. However, there was a lack of specific literature guiding primary care 
providers (PCPs) in identifying and supporting individuals with DM 2 experiencing FI. Further, 
while it appeared clear that FI had a profound effect on glycemic control and subsequent 
complications, the effect of FI on food only partly explained the relationship. Other mechanisms 
of influence remained unclear. In order for providers to aid in the management of DM 2 amongst 
individuals experiencing FI, all mechanisms of influence must be understood and strategies to 
identify FI, elicited. 
 Through these prior findings, the following question was produced: “What strategies can 
nurse practitioners employ to identify FI in primary care to enhance the management of DM 2 
amongst individuals experiencing FI?” An integrative review methodology (IRM) was selected 
since IRMs identify and amalgamate a vast array of literature to provide greater insight into 
clinical questions (Whittemore & Knalf, 2005). Whittemore and Knalf’s (2005) approach to an 
integrative review was used to guide this paper.  
Literature Search 
 A systematic approach was employed, using databases to search available literature. 
Afterwards, an additional search strategy was conducted for individual selection of key articles. 
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Inclusion and exclusion criteria were established that guaranteed a breadth of articles were 
selected that also focused the literature relevant to the topic. A descriptive analysis of the 
literature search strategy is provided followed by data evaluation and analysis using Whitemore 
and Knalf’s (2005) approach to integrative reviews.  
Preliminary Search Strategies 
 An initial scoping of the literature was conducted in PubMed to review pertinent 
keywords and medical subject heading (MeSH) terms used in articles discussing DM 2, FI and FI 
screening methodologies. Terms frequently used in the articles from prior scholarly work were 
also examined. Terms returning irrelevant literature were first cross-examined against other 
popular terms to ensure no relevant articles were missed. Some duplicate articles arose, but no 
new articles; therefore, terms returning a high volume of irrelevant literature were eliminated. 
Scope notes were examined for each MeSH heading. Reviewing keywords within MeSH terms 
and scope notes ensured terms were accurate, relevant to the project aim, suitable for the search 
strategy and not limiting to the search strategy by erroneous keyword selection or omission. A 
concept map with important keywords was used to guide the literature search strategy for each 
database. The concept map is presented in Diagram 1. 
 
 
 
 
 
 
 
30 
 
       
Diagram 1 
Concept Map Driven by PubMed MeSH and Keywords3 
 
 
 
 
 
 
 
 
 
 
 
Primary Search Strategies 
 For each aim of the integrative review, a combination of MeSH terms and keywords were 
used. Their appropriateness was verified for accuracy by comparing the scope note and cross-
examining the terms and notes against the PubMed terms initially established. For each database, 
missing terms under the MeSH heading were added as keyword search terms. New terms 
discovered under MeSH headings were independently searched to establish if additional relevant 
articles were returned. If no extra articles were found, the term was eliminated. Combining 
search strategies for all aims returned zero articles. Therefore, the search strategy was divided as 
follows: For aim 1 and 2, the Cumulative Index of Nursing and Allied Health. 
                                                          
3 “*” indicates word is truncated and includes all possible endings to the truncated word. 
MeSH: Food Supply 
 
Research Question 
MeSH: Patient Health 
Questionnaire AND Mass 
Screening 
 
MeSH: Diabetes Mellitus, 
Type 2 
 
Adult-onset Diabetes 
Mellitus 
Type 2 Diabetes 
Non-insulin dependent 
diabetes mellitus 
NIDDM 
Food Securit* 
Food Insecurit* 
Food Supplies 
Food Supply 
 
Mass Screenings 
Screening, Mass 
Screenings, Mass 
Screening 
Screenings 
Questionnaires 
Survey 
Medical questionnaire 
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Literature (CINAHL), Medline (Ovid), PubMed, Cochrane Databases (EBMR), and Academic 
Search Complete (ASC) were searched. For aims 1 and 2, the following search terms were used 
in each database and verified with the university librarian. They are presented in Table 1.  
Table 1 
Search Terms Utilized in Specified Databases to Extract Articles for Aim 1 and 2 
CINAHL Medline OVID PubMed EBMR ASC 
MeSH terms  
Food Security 
Diabetes 
Mellitus, Type 2 
 
Keywords 
Food Insecurity  
 
MeSH terms 
Food Supply 
Diabetes 
Mellitus, Type 2 
 
Keywords 
 
 
MeSH terms 
Food Supply 
Diabetes Mellitus, 
Type 2 
 
No Keywords 
No MeSH terms 
available 
 
 
 
Keywords 
Food securit* 
Food Insecurit* 
Food Supply 
Adult-onset 
Diabetes 
Mellitus 
Type 2 Diabetes  
Non-insulin 
Dependent 
Diabetes 
mellitus 
NIDDM  
Diabetes 
Mellitus Type 2 
MeSH terms 
Food Security 
Non-insulin 
Dependent 
Diabetes 
No keywords 
 
 For aim number 3, PubMed, ASC and Web of Science (WOS) were used, following a 
discussion with the university librarian. Several adjustments were made in ASC due to the 
number of results returned, bearing no relevance to the review. Appropriate terms were identified 
searching MeSH headings and comparing scope notes with PubMed. For aim number 3, the 
results for the search strategy are presented in Table 2. 
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Table 2 
Search Terms Utilized in Specified Databases to Extract Articles for Aim 3 
PubMed WOS ASC 
MeSH terms 
Food supply  
Patient health questionnaire 
Mass Screening  
 
 
No Keywords 
No MeSH terms 
 
 
 
 
 
Keywords 
Patient health questionnaire 
Screening  
Questionnaire 
Food security  
Food insecurity  
MeSH terms 
Food security  
Medical Screening 
Patient Screening 
Questionnaire 
 
No Keywords  
 
  
 Terms were then combined with the Boolean operators “AND” and “OR” when 
appropriate. The search strategy for each database was verified with the university librarian and 
is presented in Table 3. 
Table 3 
Sequential Search Strategy Utilized for the Database Searches 
Search Search Terms-Keyword and MeSH 
#1 “Food Security” OR “Food Insecurity” OR “Food Supply”  
#2 “Diabetes mellitus, Type 2” OR “Non-insulin dependent diabetes” OR 
“NIDDM” OR “Adult-onset Diabetes Mellitus” OR “Type 2 Diabetes”  
#3 #1 AND #2 
#4 “Patient Health Questionnaire” OR “Mass screening” OR “Medical 
Screening” OR “Patient Screening” OR “Screening” OR “Questionnaire” 
#5 #1 AND #4 
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 Inclusion and exclusion criteria. 
 Inclusion and exclusion criteria assisted in isolating and identifying relevant literature 
that addressed: (a) methods available to identify FI, and (b) how FI influences the management 
of DM 2. Inclusion and exclusion criteria are presented in Table 4. 
Table 4 
Inclusion and Exclusion Eligibility Criteria for the Selected Literature 
Inclusion Criteria Exclusion Criteria 
The study was published in the last 10 years 
 
The study addressed age-specific or cultural-
specific populations 
 
The study critically examined questionnaires, 
screening tools & surveys that identify FI 
 
The study did not critically assess the FI 
screening method  
Study examined the influence of FI on type 2 
diabetes 
The study examined the influence of FI on the 
development of DM 2 
 
The study contained any definition or concept 
of food insecurity (including individual and 
household food insecurity) 
 
Study was in English  
The study exclusively focused on screening 
and identifying food insecure pediatric 
patients 
 
Study was in a language other than English 
  
 Articles included in this review examined either one of the following: (a) the influence of 
FI on the management of DM 2 or (b) methods of identifying FI. Articles examining methods of 
identifying FI were not restricted to individuals with DM 2, since there was a paucity of 
literature noted during preliminary search strategies when terms were combined. Furthermore, 
there was a dearth of literature examining the identification of FI in primary care in Canada. 
Therefore, the search strategy was expanded to include all methods and environments where 
food insecurity was identified. Similarly, preliminary search strategies revealed that methods for 
identifying FI were varied and often contingent upon the study’s specific interest in FI. For 
example, some studies examined food insecurity secondary to financial constraints using tools 
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only validated to identify the same. Therefore, all tools, methods, questionnaires and surveys 
were considered. 
 While some consensus on the definition of food insecurity has been established 
internationally (WHO, 2018), there is no established consensus in the literature and definitions 
remain quite varied. Subsequently, no limitations were placed on the basis of definitions used. 
Furthermore, part of the review aimed to conceptualize the definition of food insecurity in the 
context of DM 2, therefore a breadth of literature examining the relationship of FI and DM 2 was 
sought.  No limitation was placed on age as DM 2 is almost exclusively adult-onset (Brasher, 
Jones & Huether, 2014b). For this reason, any study examining methods of identifying FI among 
pediatric populations were excluded. To avoid difficulty in generalizing and applying results to a 
Canadian context, articles discussing either DM 2 or FI within a specific cultural or social 
context were eliminated. The relationship between DM 2 and FI is complex (Essien et al., 2016), 
interacting at various levels of disease. In order to extract data pertaining to the influence of FI 
on the management of DM 2, articles examining the risk of developing DM 2 with FI were 
excluded. 
 Only articles published in English and within the last 10 years were included. Our 
understanding of DM 2 has significantly changed over the last 20 years (Defronzo, 2009). 
Subsequently, management strategies have also changed, especially over the last decade 
(Diabetes Canada, 2017b; Lipscombe et al., 2018). Literature was limited to reflect our current 
understanding and management of DM 2.  
Secondary Search Strategies 
 The cumulative search returned a total of 532 articles following the exclusion of articles 
related to the date and language exclusion criteria. Following the removal of all duplicate 
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articles, a total of 411 remained. Next, each title and abstract were screened to determine their 
relevancy to the review, using the eligibility criteria from Table 4. This process yielded 55 
articles that were eligible for full text review. 
 Several hand searches were completed. Firstly, Pubmed database was searched by 
observing “related searches” in the side bar. Next, the UNBC library general search database was 
searched using various combinations of the keywords from Tables 1 and 2. Lastly, google 
scholar was searched using the same method as with the UNBC library database. The cumulative 
hand search efforts yielded three more articles. 
 A review of the references of the remaining articles was completed to establish whether 
any relevant articles were missed in the database search. The reference search did not elicit any 
additional articles. The remaining 60 full articles were carefully examined using the full 
inclusion and exclusion criteria. Further, the references of review articles were screened to 
ensure that articles included in the full text review had not been previously included, evaluated 
and summarized in one of the extracted review articles. Fifteen articles in total were extracted for 
the literature review. Two search diagrams are presented in Appendix A.  Combined, they 
represent the results of this literature search.  
Data Evaluation and Analysis 
 A review matrix was used to assess and classify data from the final literature set of 
articles. An extensive appraisal of literature is required for a robust integrative literature review 
(Whitemore & Knalf, 2005). The Critical Appraisal Skills Programme (CASP) systematic 
review, case control, and qualitative study checklists were utilized to evaluate the quality of the 
literature (CASP, 2017). As there was no cross-sectional analysis checklist, the case control 
checklist was utilized in its stead to evaluate cross-sectional studies. Each article was evaluated 
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and assigned a quality rating using the guidelines and prompts provided by the CASP tools. The 
literature review matrix and ratings are found in Appendix B. 
 In order to guarantee bias is not introduced by the evaluator, data analysis requires both a 
synthesis of literature and systematic review (Whitemore & Knalf, 2005). The first step in  
Whitemore and Knalf’s (2005) data analysis is data reduction. Data reduction was accomplished 
in this literature review by classifying the methodologies used in each article. 
Details extracted from the literature review matrix were included under the headings: “aim”, 
“study design and sampling”, “methods and analysis” and “strengths and limitations”. Findings 
particular to each study aim were displayed in a separate column of the review matrix titled 
“findings”. Findings included in the matrix were: (a) how FI is defined in the context of DM2, 
(b) how FI influences the management of DM 2, and (c) methods used to identify FI. Whitemore 
and Knalf (2005) indicate that validating and drawing conclusions from condensed data sets can 
assist in interpreting findings. Data comparison, the final step of analysis, highlighted patterns 
within the literature. This was accomplished by creating an additional table, whereby all study 
findings were re-arranged into common themes and subthemes. The following chapter discusses 
the findings and data synthesis from the literature. 
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Chapter 4 
Findings  
 Through a comprehensive search, nine articles were identified that addressed food 
insecurity (FI) in connection with Type 2 Diabetes (DM 2), and six were identified that 
addressed methods of identifying food insecurity. The final set of articles included: 5 reviews (3 
systematic, 2 focused literature reviews), 1 combined systematic review with a qualitative study, 
1 longitudinal observational study, 1 case control study, and 6 cross sectional studies.  
 This literature review sought to explore food insecurity with relevance to a Canadian 
context. As such, Canadian and countries of similar context were sought wherever possible. 
Thirteen percent of articles were conducted in Canada, 53% of the selected articles were 
conducted in the United States (US) and the remaining 34% were conducted in various other 
countries. Of the remaining 34%, all but one of these articles were reviews covering articles from 
multiple countries. Combined, the reviews extracted accounted for most of the literature 
available from Canada and the US. The methods, key findings, strengths, and limitations were 
extracted from each article and are displayed in the literature review matrix in Appendix B. The 
CASP tool was used and modified as necessary to assist in critiquing and appraising the content 
and quality of the selected articles. Four themes arose from the literature review highlighting 
how DM 2 is affected by FI, and how FI screening can be used to improve the management of 
DM 2. These themes were: 
 1. Underlying mechanisms between FI and the management of DM 2 
 2. Hierarchies of need and motivation 
 3. Strategies to identify FI 
 4. Clinical approaches  
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 The research question was indirectly addressed by highlighting three underlying 
mechanisms of influence (food behaviors, medication use, mental health) and three established 
hierarchical needs (food consistency, social support, self-efficacy). The research question was 
directly answered by focusing on strategies that effectively identify food insecurity (selecting 
corresponding definitions, measurements, and tools), and discussing clinical approaches. The 
identified themes are discussed in the following sections. 
Underlying Mechanisms of Influence 
 
 This review highlights that the influence of FI on the management of DM 2 is significant: 
There is a near independent effect of FI on diabetes control (Shalowitz et al., 2017), which 
occurs in an increasing dose-response manner (Ippolito et al., 2016). As a result, individuals are 
at a significant increased risk for both hyperglycemia, hypoglycemia and overall poor diabetes 
control (Essien et al., 2016).  Ippolito et al (2016) found that hypoglycemic episodes are more 
frequent and severe with FI, and Shalowitz et al. (2017) found that glycemic control and A1C are 
more challenging to manage as the severity of FI increases. Understanding the mechanisms 
through which FI influences DM 2 is critical to its optimal management.  Common underlying 
mechanisms arose from the literature regarding FI and its influence on the management of DM 2. 
These mechanisms include changes in food behaviors, medication adherence and mental health.   
 Changes in food behaviors. 
 
 The literature highlighted that DM 2 was more likely to be poorly controlled as a result of 
changes in food behaviors secondary to FI. Two separate studies attempted to examine food 
behavior changes amongst individuals with DM 2 experiencing FI (Bawadi et al., 2012; Essien et 
al., 2016). Essien et al., (2016) examined the influence of FI on DM 2 an extensive focused 
literature review. They defined FI as uncertain or limited access to adequate and safe amounts of 
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food” (Essien et al., 2016, p. 78). They found that when food affordability was the main driver 
for FI, food behavior changes may occur as a compensatory strategy. For example, individuals 
may frequently engage in binge-fast cycles coinciding with pay cycles, subsequently 
experiencing widely varied dysglycemia throughout the month (Essien et al., 2016). 
Hypoglycemic episodes occur more frequently when individuals fast in times of low income, but 
their medication regimens remain unchanged (Essien et al., 2016). Several studies examined by 
Essien et al. (2016) found that hypoglycemia occurred significantly more often individuals with 
income-associated FI (AIFI). In one study, Essien et al. (2016) found hospital visits secondary to 
hypoglycemic episodes increased by 27% at the end of the month amongst low-income 
individuals, compared to the first week of the month. Furthermore, hyperglycemic events also 
appeared to occur according to pay-cycles, resulting in food binging when it is available. The 
exact cause for binging remains unclear in the literature, but appears partly driven by FI-
associated stress and anxiety and sudden availability of food following a fast (Essien et al., 
2016). It is unclear whether binge-fast cycles occur in other FI groups who are financially secure. 
 Essien et al. (2016) also found overall poor dietary choices are associated with FI: 
Individuals with AIFI consumed more saturated fats, simple carbohydrates, highly processed 
foods and less fruits and vegetables contributing to overall inferior glycemic control (Essien et 
al., 2016). Most studies were cross-sectional designs; therefore, the relationship is associative. 
However, it is speculated that these changes in food behaviors occur in IAFI because they are 
cheaper and consumed more readily (Essien et al., 2016). Essien et al., (2016) do not describe the 
food behaviors of income secure-food insecure individuals. Distress associated with FI and 
interferes with the management of DM 2 (Essien et al., 2016). However, Essien et al., (2016) do 
not comment on whether poor self-management interferes with food behaviors.  
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 While this focused literature review covered a substantial amount of material, the 
strength of the findings is limited by several factors: This literature review did not explain 
individual study strengths and limitations, therefore it is difficult to comment on the strength of 
the findings. Most studies were of cross-sectional or longitudinal design, meaning no cause and 
affect can be established, nor can the complex relationship between FI, food behaviors and DM 2 
be further explained. Further, it is difficult to generalize the results because studies came from 
varying countries. Each nation’s healthcare model, coverage, insurance and circumstance 
influence overall diabetes control. Lastly, these particular findings are limited to the IAFI 
subgroup. No conclusions can be drawn about food behaviors amongst income-secure 
individuals with DM 2 experiencing FI.  
 Bawadi et al. (2011) found similar results in their cross-sectional study examining the 
relationship of FI to glycemic control. Nearly 100% of individuals with severe FI engaged in 
compensatory food behaviors to avoid running out of food at the end of the month including 
meal skipping or cutting portion sizes, and that there was a corresponding worsening of glycemic 
control with increasing FI severity ([p <0.04], Bawadi et al., 2011). The authors also found that 
worsening FI was associated with increasing difficulties in consuming a balanced meal: 
approximately 70% of individuals who identified as food insecure could not afford balanced 
meals (Bawadi et al., 2011). Additionally, increasing FI severity was associated with greater 
sugar intake, despite caloric intake remaining similar across food security groups (Bawadi et al., 
2011). These findings suggest that the ratio of carbohydrates among FI groups is greater than 
food secure counterparts. This may account, in part, for worsening glycemic control. 
Interestingly, Bawadi et al., 2011 defined FI as “limited or uncertain availability of nutritionally 
adequate and safe foods in socially acceptable ways (p.250).” However, this study used the 
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HFSSM-sf questionnaire. While it is validated to use in multiple countries, it is only validated to 
measure AIFI. It is then, unclear, if the results were then intended to be generalized to all 
individuals experiencing FI. Irrespective of intent, the results of this study can be only applied to 
a subgroup of IAFI.  
 Unfortunately, several limitations exist: Most importantly, this study used cross sectional 
design, therefore the results are associative, not causational. Based on this study’s parameters, no 
further understanding can be gleaned surrounding relationship between food behaviors, FI, and 
DM 2 management. Additionally, there was no power calculation. Power analyses are usually 
completed before a study begins, in order to establish the sample size required for the statistical 
analysis to reliably detect what it is aiming to measure (Sutherland, 2017b). Similar to other 
studies, the use of questionnaires is always subject to recall bias. It is also difficult to generalize 
the result from a Jordanian study as the healthcare system is a variable not controlled for across 
studies.  
 Changing food behaviors appears to occur primarily amongst individuals with IAFI, and 
can affect overall glycemic control and safety. Care should be taken to identify this subset 
population of FI individuals to ensure their unique risks are identified and mitigated. It is 
speculated that income influences the quantity, quality and temporal aspect of food consumption. 
Due to the nature of the studies, however, this relationship is not well understood and the 
research does not clarify how much less food is consumed, which specific foods and how 
frequently. Further the magnitude of impact of these food behaviors compared with FS 
counterparts is not well understood.  
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Hierarchy of eating patterns. 
 The compensatory food behaviors discussed by Essien et al., (2016) highlight a pattern of 
eating motivated by basic physiological needs rather than from a desire to manage DM 2. 
Consuming food to managing DM 2 appears to be superseded by the immediacy of insufficient 
access to consistent food (Essien et al., 2016). Essien et al. (2016) found that when consumption 
of food is uncertain due to finances, eating what is accessible, available and affordable appears to 
take precedence (Essien et al., 2016).  
 FI may also re-prioritize an individual’s motivations for eating in other ways: When 
hypoglycemia occurs, Essien et al. (2016) found that individuals experiencing FI may be forced 
to eat whatever is available to them to correct hypoglycemia or to prevent hypoglycemic risks 
associated with their medications, instead of eating to maintain proper glycemic control. 
Subsequently, this may increase the risk of reactionary hyperglycemia, poorer glycemic control 
over time, and more prescriptions (Essien et al., 2016). 
 Clinical approach. 
 A literature review by Thomas, Fitzpatrick, Sidani, & Gucciardi (2018) examined the 
management of individuals with DM 2 experiencing FI and suggest several important clinical 
approaches: (1) each individual who screens positive for FI be assessed for hypoglycemia risk 
and occurrence; (2) nutrition recommendations be individualized to respect the individual’s 
capacity to manage a diabetic diet; (3) information on low-cost, but effective methods of treating 
hypoglycemia be provided; and (4) referrals to dietitians and social workers be considered as 
they may play a supportive role in managing FI (Thomas et al., 2018).  
 Thomas et al. (2018) recommend connecting identified patients with low cost food 
options within the community, including known local community food banks, kitchens, and low-
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cost grocery stores. Depending on jurisdictions, application for Special Diet Allowance funding 
may be appropriate (Thomas et al., 2018). Unfortunately, this systematic review had several 
limitations: Firstly, the authors did not discuss their critical appraisal of the evidence, what level 
of evidence informed each recommendation, how the findings were synthesized and whether 
they were based on one or more studies. Therefore, the strength and level of evidence of the 
recommendations are unclear. Additionally, Thomas et al., (2018) defined FI as “inadequate 
access to food because of financial constraints (p.258)”, but it is unclear whether the studies 
included in the systematic review measured and identified FI similarly. Lastly, if Thomas et al., 
(2018) restricted their studies to IAFI, then it is challenging to generalize these recommendations 
to the general population experiencing FI. 
 In support of these findings, the review by Essien et al. (2016) found that dietary quality 
and A1C levels improved with healthy supplemental food assistance programs (SNAP) and self-
management education support programs both improve glycemic control amongst individuals 
with IAFI. These findings are limited by a lack of qualifying information describing the nature of 
the SNAP program (i.e. which foods) and which self-management education strategies result in 
glycemic improvements. These results are also limited to the subset population of individuals 
experiencing IAFI.   
 In contrast, Ippolito et al. (2016) examined the association between food security (FS) 
and diabetes self-management in individuals already accessing food pantries. Their findings 
suggest that food pantries and banks alone do not appear to mitigate food insecurity or its effect 
on the management of DM 2. Only 16% of individuals accessing the food bank self-rated as food 
secure, while the majority, 42%, continued to report very low food security (Ippolito et al., 
2017). Further, compared to the food secure group, the very low food secure group continued to 
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report greater diabetes distress (p < 0.001), decreased diabetes self-efficacy (p < 0.001), 
medication adherence (p < 0.001), severe hypoglycemic episodes (p < 0.001; OR 2.63), and 
depressive symptoms (p < 0.001; OR 4.56], Ippolito et al., 2016). These findings suggest that 
access to food banks and food supply alone is insufficient in mitigating FI. The results of this 
study demonstrated strong statistical significance, and odds ratios demonstrates strong clinical 
significance. Similar to other studies, these results were limited by cross-sectional design, and 
the levels of food insecurity (food secure, low food secure and very low food secure) were 
decided by convention.  
Changes in mental health.  
 
 While depression is common among chronic diseases, this review of the literature 
suggests that rates of distress and depression are elevated and are further compounded by chronic 
FI (Essien et al., 2016; Ippolito et al., 2016). These changes in mental health influence the 
management of DM 2 (Essien et al., 2016; Walker et al., 2018): In a cross-sectional study, 
Walker, Williams and Egede, (2018) examined direct and indirect pathways through which FI 
influences diabetes self care behaviors and glycemic control. Diabetic self-care behaviors were 
defined as healthy eating, exercising, self-monitoring of blood glucose and foot checks and 
glycemic control was measured by A1C levels (Walker et al., 2018). They found FI that is 
significantly associated with stress (p <0.001) and increased A1C levels (p< 0.03). Further the 
higher participants perceived their level of stress, the poorer their capacity to engage in self-care 
behaviours (p < 0.001). This study did not demonstrate statistically significant worsening of A1C 
from poorer self-care behaviors (Walker et al., 2018). However, poor self-care behaviors do not 
have immediate effects on glycemic control or diabetic complications, therefore this relationship 
may be difficult to capture in cross-sectional design. Similar findings were found by Essien et al., 
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(2016) in their systematic review. One study in Essien’s review found that depressive symptoms 
were associated with lower self-efficacy leading to poorer glycemic control. It is speculated that 
the superimposed stress of diabetes on FI creates feelings of powerlessness (Essien et al., 2016). 
Self-efficacy is not defined; therefore, it is challenging to understand how mental health 
specifically influence diabetes management in individuals with FI.  
 In another cross-sectional study, Montgomery, Lu, Ratliff and Mezuk (2017) found that a 
dose-response relationship exists between FI and depression (p > 0.001) Mild FI is associated 
with 2.5-fold increase in mild depression and severe FI with a 3.5-fold increase in depression 
(Montgomery et al., 2017). Unfortunately, this study does not draw connections between 
depression and to diabetes control, therefore its clinical significant to diabetes management 
remain unclear.  
 Hierarchy of social need. 
 Social support emerged as a requisite need amongst individuals with DM 2 experiencing 
FI. Kollannoor-Samuel et al., (2011) found increased depressive symptoms were associated with 
an increased perceived interference of FI on the management of DM 2 (p <0.001), and increased 
diabetes-related clinical symptoms (p <0.001). Social support, however, mitigated depressive 
symptoms (p <0.01). Social support was defined by Kollannoor-Samuel et al., (2011) as the 
participants’ perceptions of consistent support when needed from friends and family, and was 
captured using validated 11-item questionnaire called the Multi-Dimensional Diabetes 
Questionnaire. FI was defined as “limited access, availability, or intake of nutritionally adequate 
foods” (Kollannoor-Samuel et al., 2011, p. 986). In their study, Kollannoor-Samuel et al., (2011) 
found consistent informal support from friends and family provided a buffering effect against 
depression and distress amongst individuals with FI. An inverse relationship between social 
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support and depression levels were noted (Kollannoor-Samuel et al., 2011). Further, as FI 
intensified, the influence of social support on depression was more profound (Kollannoor-
Samuel et al., 2011). These results suggest that social support is an important buffer amongst the 
most food insecure individuals. An important strength to the findings was that a post-hoc alpha 
Cronbach demonstrated internal consistency and reliability of the surveys used. Important 
limitations to this study were its cross-sectional design, and an inability to control for underlying 
genetic predispositions for depression. Further, perceived social support is limited by recall bias 
and a limited generalizability of study findings because the study population consisted of mostly 
Puerto Rican female participants. Further, there was no power calculation, therefore it is difficult 
to ascertain if the study was sufficiently powered to demonstrate small variations for its sample 
size. Importantly, Kollanoor-Samuel et al., (2011) used the short-form Household Food Security 
Supplement Module (HFSSM-sf) as a FI screening tool. This tool is validated only to capture 
income-associated FI (IAFI), therefore these findings are limited to this subset population of FI 
individuals.  
   Walker et al. (2018) also found social support mitigated the effects of stress and 
depression on DM 2 amongst individuals with FI. In this study, Walker et al. (2018) defined FI 
as an “inability or limitation to accessing nutritionally adequate foods, or a dependence on 
emergency food supplies (p.3237)”. Walker et al. (2018) examined the pathways through which 
FI influences glycemic control in individuals with DM 2, and found that FI is directly related to 
an increased glycated hemoglobin (Hb A1C) through increased stress. Further, Walker et al. 
(2018) found FI is indirectly related to an increased Hb A1C through poor self-care behaviors 
driven by stress and low social support. Social support appeared to mitigate these pathways (p < 
0.001).  Social support was defined as positive social interaction using a 3-item survey, and 
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included (1) when individuals could identify others with whom they could have a good time 
with, (2) with whom they could get together regularly and (3) with whom they could relax or do 
something enjoyable (Walker et al., 2018). Individuals scoring lower on this social interaction 
scale experienced a significantly higher level of stress directly interfering with diabetes 
management ([p < 0.001]; Walker et al., 2018). These findings suggest that facilitating social 
support can improve glycemic control in individuals with FI by increasing an individual’s 
capacity to engage in diabetes self-care behaviors and by directly lowering stress levels.  
 The results by Walker et al., (2018) are more reliable. A calculated power indicates that 
the sample size was large enough to accurately capture the associations between FI, stress, and 
DM 2 management. The results of the findings were highly statistically significant (0.05-0.0001) 
within narrow confidence intervals. Further, well-validated questionnaires were used. Similar to 
Kollanoor-Samuel et al., (2011), the results are limited by cross-sectional design, the use of self-
report questionnaires and are subject to recall bias. 
 Overall, both studies highlight how addressing nutrition choices alone in individuals with 
DM 2 experiencing FI is insufficient strategy and requires a multi-prong approach, considerate of 
strategies that mitigate stress and depression. The findings suggest social support as a requisite to 
well-controlled diabetes amongst individuals with DM 2 experiencing FI.    
 Clinical approach. 
 Walker et al., (2018) and Thomas et al. (2018) concluded that the benefits of social 
support should be considered in addition to dietary strategies when managing individuals with 
DM 2 who are food insecure. According to Walker et al., (2018) and Kollanoor-Samuel et al., 
(2011) even promoting informal social support amongst individuals with DM 2 experiencing FI 
may decrease an individual’s overall risk of depression and therefore improve the individual’s 
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capacity to perform diabetes self-care behaviours. Thomas et al. (2018), suggest that all 
individuals with FI should be assessed for social support, and that family members should be 
encouraged, wherever possible, to be included in education and management as a means of both 
social and logistical support. It is unclear what evidence informs this recommendation. 
 Lastly, income-associated (IAFI) or financially-driven FI is common in developed 
countries (Essien et al. 2016). Kollannoor-Samuel et al., (2011) highlighted that individuals with 
DM 2 with lower household income were especially vulnerable to increased rates of depression, 
in particular, because limited income impairs an individual’s capacity to manage stress (p < 
0.03). Individuals experiencing IAFI may be additionally vulnerable to the effects of stress and 
depression, since they may be juggling the cost of basic needs such as rent, electricity, and 
clothing on top of food (Kollannoor-Samuel et al., 2011). Identifying when finances are at the 
core of FI may be necessary to address additional barriers this population may be facing, and 
consider social work involvement, recommended by Thomas et al., (2018). 
Changes in medication use. 
 
 FI appears to interfere with changes in overall medication use and safety. Several studies 
noted that medication underuse was significantly more likely to occur IAFI (Essien et al., 2016; 
Ippolito et al., 2016). “Food-medicine-health-supply trade-offs” (FMS trade-off) is a 
phenomenon that occurs when people have less money, and results in having to choose between 
purchasing food, medicine or health supplies, because the individual cannot not afford all three 
(Ippolito et al., 2016). In their study examining FI and diabetes self-management in individuals 
accessing food pantries, Ippolito et al. (2016) found that FMS trade offs were almost 7 times 
times more likely to occur in the very low food secure group, and medication affordability 4 
times more likely compared with the more food secure group of individuals with DM 2 accessing 
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food banks (p < 0.001).  The focused literature review by Essien et al. (2016) revealed similar 
findings: some included studies reported up to half of their participants with IAFI either stretched 
out medication prescriptions, delayed filling prescriptions or did not use the medications at all 
(Essien et al., 2016). Other studies in their review reported that individuals with FI were six 
times more likely to stretch out their medication prescriptions (Essien et al, 2016). Caution, 
however, must also be taken when comparing medication and supply affordability in comparison 
with American studies. For example, glucose monitors are free when tests strips are purchased in 
Canada, and test strips are part of Fair Pharmacare; meaning, low income patients will either 
have the majority or all of their strips covered based on their diabetic medication regimen 
(Government of British Columbia, 2018b). A select list of medications, previously discussed, is 
also covered under Fair Pharmacare for individuals with low income once deductibles are met 
(Government of British Columbia, 2018c). 
 Interestingly, in a cross-sectional study examining whether food insecurity is 
independently associated with delays in filling prescriptions, Bilimek and Sorkin (2012) found 
individuals with FI are two times more likely delay or not to fill their prescriptions even when all 
other variables are adjusted for (p <0.01). FI was defined as “limited or uncertain access to food 
due to inadequate financial resources (Bilimek and Sorkin, 2012, p.2160). However, the cause 
medication adherence issues without a financial drive remain unknown and are limited by study 
design. One important limitation to this study is that assume individuals below poverty line are 
only classified with IAFI, and does consider other populations of IAFI. The study also does not 
perform a power analysis to ensure enough participants were recruited to power the findings. 
Lastly, even though multivariable logistic regression analysis shows, medication adherence 
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issues is statistically significant for reasons other than finances, this has yet to be demonstrated 
as a primary outcome among all individuals with FI.  
 In contrast, Shalowitz et al. (2017), sought to determine whether FI is associated with 
poor glucose control over time, and found that insulin use increases over time (p < 0.010). The 
authors comment that insulin use and its initiation, however, is associated with and is a predictor 
of increasing A1C over time (Shalowitz et al., 2017). Therefore, increased insulin use in 
individuals with FI is a consequence of dysglycemia, rather than a demonstration of medication 
adherence (Shalowitz et al., 2017). Longitudinal study design does not prove causality of 
findings the findings. Further no power analysis was performed. Irrespective of reason, increased 
use of insulin over time, brings into question medication adherence amongst FI populations. 
 An important finding that emerged from the literature review by Essien et al., (2016):  In 
considering changes to food behaviors, a significant risk of medication-glycemia mismatch exists 
when: (1) food becomes scarce but medication regimens remain unchanged, or (2) food 
consumption is maintained at the expense of discontinuing medications (Essien et al., 2016). A 
high risk of hypoglycemia can also contribute when the provider does not understand food 
consumption behaviors These findings highlight important safety concerns and the importance of 
addressing medication regimens and adherence in the presence of FI.  
Clinical approach.   
 Thomas et al., (2018) suggest the following pharmacological approach of individuals 
with DM 2 experiencing FI. Firstly, understand a client’s medication coverage, and then consider 
replacing antihyperglycemics with the greatest risk of hypoglycemia with safer alternatives 
(Thomas et al., 2018). If taking insulin, consider a regimen that is more flexible (Thomas et al., 
2018). Further, consider scheduling medications with meals wherever appropriate, and 
51 
 
       
withholding when there is no food intake (Thomas et al., 2018). Lastly, Thomas et al. (2018) 
suggest that less stringent glycemic targets should be considered. Unfortunately, a lacking 
critical analysis of the evidence limits the strength of these findings. 
 Reduced self-efficacy.  
 Within the literature a theme emerged related to FI and an overall decreased self-efficacy. 
Ippolito et al., (2016) define self-efficacy as an individual’s belief in his or her own capacity to 
manage his or her diabetes. Self-efficacy is a key aspect in chronic disease self-management 
(Essien et al., 2016; Ippolito et al., 2016). Decreased self-efficacy impairs self-management 
behaviors such as following a diet, resulting in inferior diabetes control (Essien et al., 2016). In 
their cross-sectional design examining the association between FI and diabetes self-management, 
Ippolito et al., (2016) used an eight-item instrument validated to measure self-efficacy and used 
Likert scale to establish mean result for each subset group of food security: Food secure, low 
food secure and very low food secure (Ippolito et all., 2016). Lower self-efficacy scores are 
usually correlate with worse A1C scores (Ippolito et all., 2016). This study found overall 
decreased self-efficacy interfered with diabetes self-management, on average, 36% more often in 
severe FI individuals, relative to food secure participants (p < 0.001). This, however, did not 
translate into inferior A1C control and the underlying mechanism is unclear due to the nature of 
cross-sectional studies. Further, it is unclear how self-management behaviors are affected.  
 These trends in self-care behaviors were also noted by Gucciardi et al., (2009), who 
found that FI was associated with decreased self-efficacy and individuals were more likely to be 
physically inactive, be overweight, eat less fruits and vegetables, be twice as likely to be a 
smoker, be twice as likely to report stress, and report lower general health, mental health and 
perceived stress. Essien et al. (2016) offer one mechanism through which self-efficacy may be 
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impaired: competing demands between food and managing DM 2 may precipitate chronic stress, 
distress, and depression contributing to a reduced mental capacity, and elicit feelings of 
powerlessness that diminish one’s self-efficacy (Essien et al., 2016). Self-efficacy is not defined 
by Essien et al. (2016), affecting the clarity of findings. 
 Clinical approach. 
 Evidence is limited in providing strategies to improve self-efficacy; however, it appears 
that if depression, distress and stress are mechanisms through which self-efficacy is hampered 
(Essien et al., 2016), then social support as described by (Kollannoor-Samuel et al., 2011) may 
be one clinical approach to improve self-efficacy. Caution must be taken in these 
recommendations due to a lack of supporting evidence.  
Screening for Food Insecurity  
 The findings from this literature suggest screening for FI can be successfully 
implemented in the healthcare setting. Studies demonstrated most patients and care providers 
involved in the FI screening felt the healthcare setting was both beneficial and appropriate (De 
Marchis et al., 2019; Thomas et al. 2018).  In a systematic review examining the validity and 
acceptability of food insecurity (FI) screening tools and their implementation in health care 
settings, De Marchis et al. (2019) found that between 66-88% of patients screened for FI found it 
appropriate to be asked about FI in the healthcare setting. De Marchis et al. (2019) also found 
that between 80-89% of HCP felt FI screening was appropriate during healthcare visits. The 
strength of these findings were limited by low quality to very-low quality findings from two 
qualitive and four cross sectional studies (De Marchis et al., 2019). The generalizability of the 
findings are limited to income-associated food insecurity (IAFI), because all FI screening tools 
were validated against the United States Department of Agriculture Food Security Scale (USDA-
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FSS) which is only validated to measure. Lastly, generalizability was also limited by inclusion of 
some pediatric studies in the systematic review.  
 The findings by De Marchis et al., (2019) were also in keeping with the results from a 
pilot project from Thomas et al. (2018), who examined the acceptability and feasibility of an 
implemented FI screening in healthcare using a qualitative pilot project based in a Toronto 
healthcare setting. Thomas et al. (2018) found 71% of participants were comfortable discussing 
their personal experiences of FI with their healthcare providers (HCPs). The HCPs found FI 
screening helpful in guiding care and support for patients. Further, the HCPs reported that FI 
screening brought meaning and understanding as to why patients may not follow diabetes 
management recommendations, how it impacts their ability to self-manage their diabetes and 
how they cope with FI (Thomas et al., 2018). Both the HCPs and patients found FI screening 
both relevant and non-intrusive in the healthcare setting. None of the patients reported negative 
experiences (Thomas, et al, 2018). In fact, strong rapport with their provider increased the 
likelihood of engaging in FI screening (Thomas et al., 2018). 
 Important caveats exist: De Marchis et al., (2019) found time required to complete FI 
screening tools was between 30 seconds to 10 minutes. Four out of 10 studies reported time as a 
barrier to FI screening (De Marchis et al., 2019). It is unclear whether an optimal screening time, 
or threshold existed. It should also be noted that not everyone who screens positive for FI wants 
care provider assistance, therefore judicious use of screening should be considered. 
 Clinical approach. 
 The literature review did not support one preferred method of identifying food insecurity. 
Instead, strategies emerged that focus on context-specific, individualized approaches to 
identifying FI. This strategy includes: (1) selecting a well-defined, context-specific definition of 
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food insecurity useful to the specific purpose, which (2) highlights the attributes of FI intended 
on being measured and studied, and lastly, (3) selecting a corresponding tool that measures these 
attributes. 
Selecting a definition of food insecurity (FI). 
 A context specific definition was preferred over a comprehensive and universal definition 
of FI for two reasons: (1) A diversity of FI determinants or attributes exist unique to each 
circumstance, and (2) very few attributes are antecedents. These findings are corroborated by 
Jones et al. (2013). Their systematic review of the literature attempted to conceptualize a 
universal and comprehensive definition food (in)security and found that a universally acceptable 
definition of FI unlikely to be appropriate and applicable in all circumstances (Jones et al., 2013).  
 Lack of antecedents. 
 FI is not universally defined in the literature: Twelve out of fifteen articles provided a 
definition of food insecurity. Of the twelve definitions, seven different variations emerged and 
only two antecedents. The two antecedents included: (1) uncertain or inconsistent access, and (2)  
an inadequate amount of food (Bawadi et al., 2012; Billimek & Sorkin, 2012; De Marchis et al., 
2019; Essien et al., 2016; Gucciardi et al., 2009; Ippolito et al., 2016; Jones, Ngure, Pelto, & 
Young, 2013; Kollannoor-Samuel et al., 2011; Makelarski, Abramsohn, Benjamin, Du, & 
Lindau, 2017; Montgomery et al., 2017; Shalowitz et al., 2017; Walker et al., 2018).  
 One antecedent emerged with respect to FI and DM 2: universal acknowledgement that 
FI interferes with proper diabetes management and control (Bawadi et al., 2012; Billimek & 
Sorkin, 2012; Essien et al., 2016; Gucciardi et al., 2009; Ippolito et al., 2016; Kollannoor-Samuel 
et al., 2011; Montgomery et al., 2017; Shalowitz et al., 2017; Walker et al., 2018). A final 
compilation of antecedents, “uncertain access to sufficient amounts of food which interferes with 
55 
 
       
diabetes management”, has several limitations: (1) The terms “food”, “access”, and “inadequate 
amounts” are not adequately explored or explained (Jones et al., 2013), which limits applicability 
of results. More specifically, what foods are specifically limited in access and in which amounts? 
None of the literature explored these concepts in detail. Essien et al., (2016) discussed some 
changes to food group choices such as fruits and vegetables, as well as changes to food 
behaviors; however, these are non-specific. (2) How FI interferes with diabetes management is 
multifactorial, and specific to the factors causing FI. For example, income-associated FI (AIFI) is 
specifically associated with binge-fast cycles resulting in dysglycemia, but this trend has not 
been explored amongst the general FI population. Lastly, (3) based on this review, the literature 
suggests that diabetes management is also influenced by FI in several indirect ways including 
depression, distress, diminished self-efficacy and medication behaviors. These also have not 
been explored in the literature in ways that allows for sufficient understanding and concise 
definition. Study design is a significant limiting factor to understanding the complex relationship 
and details required to be capable of defining these terms.  
 Diversity of attributes. 
 Several FI attributes emerged from the literature review, but were not universal 
antecedents. Instead, these attributes were relevant and specific to the study to which it applied. 
Attributes (or determinants) are features inherent to, or associated with FI (Jones et al., 2013). 
Attributes differ from antecedents in that they do not need to be universal in all cases of FI. 
These determinants included: (1) lack of access to nutritionally appropriate food (Bawadi et al., 
2012; Gucciardi et al., 2009; Jones et al., 2013; Kollannoor-Samuel et al., 2011; Montgomery et 
al., 2017; Shalowitz et al., 2017; Walker et al., 2018); (2) lack of access to safe foods (Bawadi et 
al., 2012; Essien et al., 2016; Gucciardi et al., 2009; Makelarski et al., 2017; Montgomery et al., 
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2017; Shalowitz et al., 2017); (3) access to food  in socially acceptable ways (Bawadi et al., 
2012; Jones et al., 2013);  (4) FI secondary to financial constraints (Billimek & Sorkin, 2012; De 
Marchis et al., 2019a; Ippolito et al., 2016; Jones et al., 2013; Shalowitz et al., 2017); and (5) 
having insufficient food to meet dietary needs to maintain a healthy and active life  (Gucciardi et 
al., 2009). Similar to the antecedents, efforts to understand and adequately define these attributes 
are not found in the literature.  
 Context-specific approach. 
 Jones et al. (2013) suggest an individualized approach to FI definitions focused on 
pertinent attributes that can be defined by the clinic or provider, and managed by a particular 
program, clinic, or individual’s resources (Jones et al., 2013). Jones et al. (2013) suggest 
disassembling the definition of FI into smaller, more manageable concepts. For example, 
income-associated FI (IAFI) or FI secondary to financial constraints occurs very frequently, but 
does not occur in all cases of food insecurity (De Marchis et al., 2019; Ippolito et al., 2016; Jones 
et al., 2013; Shalowitz et al., 2017). Identifying IAFI is important because there are several IAFI-
specific diabetic consequences that can arise (Essien et al., 2016). Medication underuse, for 
example, appears to be a problem primarily among individuals with IAFI (Essien et al., 2016). 
Using a context-specific definition focused on particular attributes of interest helps identify 
specific issues related to FI (Jones et al., 2013). Further, using a context-specific definition for FI 
assists in selecting an appropriate FI screening tool: Marques et al., (2015) and Jones et al. 
(2013) found screening tools are validated to identify and measure specific attributes of FI, rather 
than FI as comprehensive concept. For example, several tools exist that are specifically validated 
only to identify IAFI (Marques et al., 2015). Defining FI as secondary to financial constraints 
(IAFI) points to which screening tools are more appropriate for selection. 
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Selecting attributes and screening tools. 
 According to Jones et al. (2013), definitions, attributes, and screening tools should all 
align in order adequately and accurately capture what is intended on being measured. The 
literature highlighted significant limitations to this process: In their systematic review examining 
24 different FI tools from 184 different articles, Marques et al., (2015) found all included 
screening tools measured income-associated FI (IAFI) and that most key attributes of FI remain 
unanalyzed in the literature (75% of evidence rated positive or neutral). Similarly, another 
systematic review by Ashby et al., (2016) examined the attributes of eight different FI screening 
tools used in developed countries and found physical and economic access to food were only 
measured (Ashby et al., 2016).   
 Few tools attempt to measure other attributes of FI (Marques et al., 2015): The 
Radimer/Cornell tool attempts to measure food utilization, and enquires about anxiety secondary 
to required assistance in preparing food (Ashby et al., 2016). The Kuyper tool attempted 
to measure food stability or insecurity over time (Ashby et al., 2016), and only one tool 
attempted to measure both household level FI, and individual level FI (Ashby et al., 2016). A 
final systematic review by Jones et al., (2013) examined the attributes of 17 different FI 
screening tools (evidence rated low) and also found most attributes of FI were not captured in 
screening tools. Jones et al. (2013) also found food measures are not always clear about what 
attributes they are measuring, nor are the attributes consistently defined. For example, access to 
food can be further broken down to access, acquisition, consumption (Jones et a., 2013). 
However, this is often not well articulated in screening tools. It could be speculated that the lack 
of clarity surrounding attributes in screening tools may be, in part, a consequence of the lack of 
clarity surrounding FI definitions and concepts. 
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 Another limitation to FI screening is that most tools have not been significantly analyzed 
(Marques et al., 2015). Marques et al. (2015) found the Core Food Security 
Measurement/Household Food Security Survey Module (CFSM/HFSSM) is one of the few FI 
screening tools significantly analyzed in literature, while the Self-Perceived Household Food 
Security Scale (SPHFSS) and the short-form HFSSM (HFSSM-6SF) have been moderately 
analyzed in the literature. The CFSM/HFSSM and HFSSM-6SF have been studied and validated 
in many countries worldwide (Marques et al., 2016). Half of the other tools examined by 
Marques et al. (2015) had only been tested or studied in the literature one or two times (Marques 
et al., 20165). 
 In general, several challenges remain in accurately capturing individuals with FI in 
practice: screening questionnaires will always be subject to a response or recall bias (Jones et al., 
2013). Well-validated tools such as the Household Food Security Survey Module (HFSSM) and 
its short form have an internal consistency of 0.82-0.94 and have found to be valid and reliable 
(Marques et al., 2014); however, few screening tools have been so well analyzed. It remains a 
challenge that the only tools well analyzed only measure IAFI. Validating non-IAFI screening 
tools can also be challenging when they are so diverse in what they measure (Jones et al., 2013). 
FI cut-offs are also not standardized, with some studies establishing levels of FI by convention 
(Ippolito et al., 2016). Additionally, an important trade-off to consider when selecting FI tools is 
whether to use comprehensive versus short form (1 or 2 question) tools in the setting of time 
constraints. Comprehensibility and contextual detail need to be weighed against simplicity and 
comparability (Jones et al., 2013). Thus, it remains a challenge to ensure true capture of the FI 
population representative of what is intended on being identified. Based on these systematic 
reviews, there are no comprehensive tools identifying all attributes or domains of FI (Ashby et 
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al., 2016; Jones et al., 2013). While an individualized approach is certainly preferred (Jones et 
al., 2013), these findings suggest that selecting attributes of interest are significantly limited by a 
lack of diverse, well-analyzed, validated screening tools.  
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Chapter 5 
Discussion 
 Through this integrative review, several themes were elicited that highlighted the 
mechanisms of influence through which FI impacts the management of DM 2. These included 
changes in food behaviors, mental health and medication use. Strategies to identify food 
insecurity were presented. Collectively, the findings addressed the integrative review question: 
“What strategies can NPs employ to identify FI and enhance the management of DM 2 in the 
primary care setting among adults experiencing dysglycemia?” 
 The literature highlighted unique motivations for behavior and hierarchies of need which 
appeared to take precedence in the lives of individuals with DM 2 experiencing FI. Such 
mechanisms of influence also reflect the chief tenets of the MTM. As discussed, MTM suggests 
that needs occur in a hierarchical, but not mutually exclusive, manner (Maslow, 1943), and that 
humans are motivated by a desire to satisfy these needs (Maslow, 1943, p. 394). Further, real or 
perceived threats to the security of these needs can generate either emergency or compensatory 
reactions in behavior (Maslow, 1943, p. 394). 
 In MTM, food is one of the most basic physiological human needs (Maslow, 1943), 
which provides further insight into why individuals with FI struggle with higher-level needs, 
such as self-management. MTM may highlight perspectives on how NPs can provide realistic, 
FI-informed strategies that can enhance the management of DM 2. Lastly, MTM may highlight 
the enhanced value of individualized, FI-informed management strategies when patients are 
significantly limited in their capacity to self-manage their DM 2. 
 The findings from the literature review are discussed in the following section, drawing 
connections to the significance for NPs in the PC setting. Included in the discussion are  
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recommendations for NP clinical practice, followed by a discussion of the limitations and future 
research recommendations. A diagram highlighting the review findings is presented below. 
Diagram II: The impact of FI on DM 2 and strategies to improve management. 
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Theme One: Mechanisms of Influence 
 Amongst the literature there is a dearth of evidence directly informing the management of 
DM 2 amongst individuals who are FI (Thomas et al, 2018). Findings from the literature set 
predominantly examined the underlying mechanisms through which FI influences the 
management of DM 2, and recommendations for practice were drawn from these findings. These 
mechanisms are discussed in detail in the following sections. 
 Changes in food behaviors. 
 The literature highlighted that DM 2 was more likely to be poorly controlled as a result of 
poor food behaviors secondary to FI (Bawadi et al., 2012; Essien et al., 2016). Specifically, 
affordability was a major driver to changes in food behavior and often were compensatory in 
nature (Essien et al., 2016). Individuals were found to binge and fast (Essien et al., 2016), cut 
meal sizes, and skip meals (Bawadi et al., 2012) according to pay cycles, subsequently placing 
them at increased risk for dysglycemia (Essien et al., 2016). In particular, a review highlighted a 
significant increase in hypoglycemia risk, and occurrence and severity secondary to decreased 
consumption of food while maintaining the same medication regimens (Essien et al., 2016).  
 Food behaviors also appeared to influence dietary choices. Individuals with FI appeared 
to consume more saturated fats, simple carbohydrates, highly processed foods and less fruits and 
vegetables, possibly linking food behaviors to overall inferior glycemic control. While the 
relationship is associative, several authors within an examined review speculate that these foods 
are cheaper and easier to access, therefore are consumed more readily (Bawadi et al., 2012; 
Essien et al., 2016).  
 Several important clinical approaches were suggested in the literature, including 
assessing for hypoglycemia risk and occurrence amongst individuals with FI; individualizing 
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nutrition recommendations based on the individual’s resources and abilities; providing 
information on low-cost, but effective methods of treating hypoglycemia; and considering 
referrals to dietitians and social workers for additional support (Thomas et al., 2018). 
Additionally, connecting identified patients with low cost food options within the community has 
been recommend (Thomas et al., 2018). In particular, healthy supplemental food assistance 
programs paired with self-management support demonstrates evidence for improved dietary 
quality and A1C levels (Essien et al., 2016).  
 Importantly, increasing access to food may not be a sufficient strategy alone in managing 
FI.  Studies examining individuals with DM 2 accessing food banks found the majority of 
individuals still identified as food insecure and reported most, if not all, issues highlighted in this 
integrative review, including diabetes distress, decreased diabetes self-efficacy, medication 
adherence, severe hypoglycemic episodes, medication affordability issues, medicine-supply-
trade-offs, and depressive symptoms (Ippolito et al., 2016). It remains unclear whether these 
findings reflect the inadequacy of this particular food bank in providing sufficient food, in 
providing diabetic-friendly options, or whether access to food is insufficient in ameliorating FI 
amongst individuals with DM 2. 
Recommendations for Practice. 
  These findings suggest that a multi-faceted approach is necessary in food behaviors 
amongst individuals with DM 2. Primary care providers should consider their familiarity with 
resources in the community, including food banks and low-cost food stores, and determine 
whether supplemental funding exists in their jurisdiction, especially for individuals experiencing 
IAFI. Thomas et al. (2018) found that establishing a list of community resources was useful in 
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the implementation of FI screening and management in diabetes clinics, and helped increase 
access to meaningful resources. 
 PCPs should also routinely assess for hypoglycemia risk and occurrence, and consider 
pharmacological strategies to prevent this from occurring4. The literature does not suggest a 
frequency for assessment, but the Canadian Diabetes Guidelines (CDG) do suggest assessing for 
hypoglycemia amongst all individuals every visit (Yale, Paty, & Senior, 2018).  
 There are no recommendations or suggestions in the literature regarding individualized 
nutritional strategies. PCPs may consider co-management of an individualized dietary strategy 
with social work and dieticians. When individualizing a nutritional strategy, consideration should 
be taken in relation to the patient’s food resources and also the individual’s level of agency and 
self-efficacy. The CDG suggests self-management support (SMS) strategies as they focus 
directly on building a trusting and collaborative relationship, with consideration of the 
individual’s abilities and capacity (Sherifali, Berard, Gucciardi, MacDonald, & MacNeill, 2018). 
It remains unclear, however, how SMS may be used for individuals with FI who experience a 
decreased capacity for self-management (Essien et al., 2016). Future studies should examine how 
PCPs may motivate and partner with individuals with FI who face difficulties with food 
consumption, self-management and self-efficacy.  
 Changes in mental health. 
 Studies found that rates of distress and depression are elevated by chronic FI (Essien et 
al., 2016; Ippolito et al., 2016) and influence the management of DM 2 (Essien et al., 2016; 
Montgomery et al., 2017; Walker et al., 2018). Stress directly interferes with an individual’s 
ability to perform self-care behaviours such as healthy eating, exercising, self-monitoring of 
                                                          
4 See discussion section on medication use 
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blood glucose and foot checks, subsequently resulting in worsening A1C levels (Ippolito et al., 
2016). The results from the integrative review suggest a close relationship between FI, mental 
health and an individual’s capacity to self-manage their diabetes, although the exact mechanism 
remains unclear.    
 Some studies highlighted that individuals with DM 2 and lower household income are 
especially vulnerable to increased rates of depression, in particular, because limited income 
impairs an individual’s capacity to manage stress. Therefore, individuals experiencing income-
associated FI (IAFI) may be additionally vulnerable to the effects of stress and depression. 
Identifying when finances are at the core of FI may be necessary to address additional barriers 
this population may be facing, such as the cost of rent, electricity, and clothing on top of food 
(Kollannoor-Samuel et al., 2011).  
 Strategies in addressing mental health amongst individuals with DM 2 experiencing FI is 
limited amongst the studies.  Thomas et al. (2018) recommend assessing the mental health status 
of individuals experiencing FI and considering social work referrals, although the literature does 
not provide any specific strategies. 
Recommendations for practice. 
 
 Identifying mental health concerns such as depression and distress amongst individuals 
with DM 2 is recommended by the CDG (Robinson et al., 2018). The CDG provide 
recommendations as outlined below. 
 Identifying diabetes distress and major depression. 
 The CDG recommends screening for mental health in individuals with diabetes 
throughout the lifespan (Robinson et al., 2018). There is no preferred screening tool in measuring 
depression or distress, although it is important to distinguish between them (Robinson et al., 
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2018). All tools recommended by the CDG for measuring depression and distress are roughly 
equivocal in terms of sensitivity and specificity in the diabetic population (Robinson et al., 
2018). In particular, the Diabetes Distress Scale (DDS) can be used to identify individuals with 
DM 2 at risk for, or experiencing, distress and a PHQ-9 can be used to identify individuals at risk 
of, or experiencing symptoms of, a major depressive disorder (Robinson et al., 2018). Both 
scales can assist in differentiating between distress and depression, as well as provide guidance 
in practice (Robinson et al., 2018). There are no recommendations for the frequency of screening 
in the literature review, nor are there recommendations in the guidelines. Future research should 
examine whether similar strategies for identifying depression and distress are equally as affective 
amongst individuals experiencing depression and distress secondary to FI. 
 Interventions for diabetes distress and major depression 
 The CDG recommends several non-pharmacological strategies that PCPs can incorporate 
into practice that have evidence for improved mental health and diabetes control (Robinson et al., 
2018). This includes one-on-one individualized therapeutic strategies, cognitive behavioral 
therapy, motivational interviewing, family interventions, increasing self-management and coping 
skills, improving self-efficacy and stress management (Robinson et al., 2018). Further, there is 
some evidence for the use of pharmacotherapy in treating depression amongst individuals with 
DM 2, although caution must be weighed against the risk of glucose dysregulation. While 
evidence exists for mental health interventions amongst the general DM 2 population, the 
literature review found insufficient evidence promoting any specific therapeutic interventions to 
ameliorate depression and distress secondary to FI in the DM 2 population. Future studies should 
examine the efficacy of the interventions endorsed by the CDG in improving distress and 
depression amongst individuals who are FI.  
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 Changes in medication use. 
   
 Changes in overall medication use and safety was described in the literature set. Studies 
noted medication underuse was significantly more likely to occur when FI was secondary to 
finances (Essien et al., 2016; Ippolito et al., 2016). However, there is evidence to support that all 
individuals with FI are significantly more likely not to fill their prescriptions, even when cost and 
all other variables are adjusted for (Ippolito et al., 2016). Stretching out medication prescriptions, 
delaying filling prescriptions or not using the medications at all have all been attributed to FI 
(Billimek & Sorkin, 2012). While cost is implicated in medication underuse in individuals with 
FIFC, the underlying mechanisms influencing all medication underuse behaviors remain 
unknown.  
 Medication safety issues may also arise if certain medication regimens remain the same, 
despite ongoing FI (Essien et al. 2016).  FI is associated with a significantly increased risk of 
hypoglycemia secondary to medication-glycemia mismatch (Essien et al., 2016). These findings 
suggest that practitioners should be addressing medication use with all individuals who identify 
as food insecure, and that patterns of medication use may be complex and interfering with 
overall glycemic control. 
 Other unique patterns of medication use may arise when FI is secondary to financial 
constraints (FIFC): Ippolito et al. (2016) found that food-medicine-supply trade offs may occur 
when individuals cannot afford all three in order to manage their diabetes. As a result, 
dysglycemia may occur if food consumption is maintained at the expense of discontinuing 
medications. These findings highlight the importance of medicine reconciliation and addressing 
medication regimens and adherence in the presence of any individual identified as FI.  
68 
 
       
 While not a trend, one longitudinal study demonstrated that individuals with FI use more 
insulin over time (Shalowitz et al., 2017). Insulin use is a predictor of poorly controlled diabetes 
and increasing A1C over time. As a result, insulin use among individuals with FI was seen as a 
consequence of poorly-controlled dysglycemia. These findings highlight the importance of FI 
identification in practice, as there are significant consequences to increasing insulin use amongst 
a population with inconsistent or insecure food consumption, or without understanding food 
consumption behaviors.   
 Assessing a client’s medication regime, medication coverage, adherence to the regime, 
and individual risk for and occurrence of hypoglycemia, can lead to basic patient-centered 
pharmaco-education which may help guide diabetes pharmacotherapy (Thomas et al., 2018). By 
assessing for hypoglycemia that is conscious of coverage, providers can replace 
antihyperglycemics that pose the greatest risk of hypoglycemia with safer alternatives (Thomas 
et al., 2018). Further, by assessing an individual’s medication regime, providers can encourage 
insulin regimens which are more flexible, safe and patient-centered (Thomas et al., 2018). 
Simple educational strategies can help promote safety, such as promoting medications with 
meals wherever appropriate and withholding certain medications when there is no food intake 
(Thomas et al., 2018). Lastly, it is prudent to consider less stringent glycemic targets that are 
safer and conscious of an individual’s capacity to maintain glycemic control (Thomas et al., 
2018). 
 PCPs, including NPs, are ideally situated to address pharmacological strategies amongst 
individuals with DM 2 experiencing FI. PCPs are primarily responsible for overseeing the 
medical management of their patients, are familiar with Pharmacare coverage, and can 
accommodate routine follow up and monitoring. While no recommendations specific to NPs 
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were retrieved from the literature set, NPs are specifically skilled at addressing difficult 
conversations such as medication adherence, and patient difficulties in adopting behavior change 
(Bartol, 2012).  
 Recommendations for Practice. 
 Medication reconciliation should ideally occur at every patient appointment as per CDG 
(Lipscombe et al., 2018). Care should be taken to consider the dates medications were prescribed 
via Pharmanet versus the amount of prescription remaining. Since the relationship of medication 
use amongst individuals with FI is complex and may accompany feelings of distress, depression 
and powerlessness, an open-ended, non-confrontational approach should be used to further 
understand the unique patterns of behavior related to medication use. 
 FI appears to be closely associated with financial constraints in the Canadian context 
(Tarasuk et al., 2016). With approximately 1 in 8 Canadians experiencing income-associated FI 
([IAFI], Tarasuk et al., 2016), PCPs need to be cognizant of the interface between Pharmacare-
covered medication reliance (Diabetes Canada, 201b), and safe prescribing practices in the 
context of FI. Specific pharmacotherapy strategies to prevent hypoglycemia are included below, 
are thoughtful of individual regimens, and are based on the recommendations from Thomas et al. 
(2018). 
 Adjusting sulfonylureas. 
 If an individual with FI is presently taking sulfonylureas, the following considerations are 
considered prudent: educate and reinforce that sulfonylureas work fairly rapidly and do not work 
in a glucose-dependent method (Lipscombe et al., 2018). As recommended by Thomas et al. 
(2018), if meals are skipped, encourage individuals to hold their sulfonylurea dose and to 
consume only with meals. If hypoglycemia has been identified on at least one occasion, the PCP 
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should consider one of three interventions: (1) if the individual is taking glyburide, the PCP 
should apply for Special Authority (SA) to substitute glyburide for an alternate sulfonylurea 
associated with less risk of hypoglycemia, such as gliclazide (Lipscombe et al., 2018); gliclazide 
is the preferred sulfonylurea due to its superior safety profile (Lipscombe et al., 2018); (2) 
consider the A1C and whether targets needs to be softened, as sulfonylureas may need to be 
discontinued, and whether increasing metformin to maximum tolerated doses is sufficient; (3) 
apply for SA-approved DPP4 inhibitors, linagliptin or saxagliptin, in place of sulfonylureas 
(Government of British Columbia, 2018b). Importantly, the SA for DPP4 inhibitors mandates 
that NPH must be tried and found either ineffective or inappropriate (Government of British 
Columbia, 2018e). Declaring NPH inappropriate on the application for DPP4 inhibitors is 
reasonable given the evidence surrounding FI and inconsistent food intake (Essien et al., 2016), a 
subsequent significant increased risk of hypoglycemia (Essien et al., 2016; Ippolito et al., 2016), 
significant harms associated with hypoglycemia (Yale et al., 2018), and the potential for 
nocturnal hypoglycemia with NPH (Lipscombe et al., 2018). This is supported by the Canadian 
Diabetes Guidelines (CDG), which recommends that medications with potential for 
hypoglycemia be avoided amongst individuals with high risk of hypoglycemia (Yale et al., 
2018). Furthermore, the CDG supports the use of newer agents such as DPP4 inhibitors due to 
their safety profile and non-inferior A1C-lowering abilities (Lipscombe et al., 2018). 
Changing insulin regimes. 
 If patients with FI are already taking insulins or require insulins, it would be prudent to 
consider one of the following options: (1) if the treatment of an individual with DM 2 has 
progressed in that they require exogenous intermediate acting insulin such as NPH, assess 
whether nocturnal hypoglycemia has been identified on at least one occasion within the last 
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month. SA for long-acting insulin Detemir should be considered as per SA criteria (Government 
of British Columbia, 2017f) for individuals experiencing hypoglycemia. As above, NPH presents 
challenges to the individual with DM 2 experiencing FI, but Detemir does not have a peak effect 
(Lipscombe et al., 2018); (2) if the treatment of an individual with DM 2 has progressed in  that 
they require exogenous short acting insulin, consider if rapid acting insulin is both affordable and 
appropriate, as it poses less risk of postprandial hypoglycemia compared to short-acting insulins 
(Lipscombe et al., 2018). Other considerations in keeping with Thomas et al.’s (2018) findings 
include decreasing overall postprandial targets and insulin dosing, and educating on dose-holding 
when meals are skipped. 
 Other strategies that enhance pharmacotherapy. 
 Evidence is limited for increasing SMBG frequency beyond what is recommended by the 
CDG for each individual class of pharmacotherapy (Berard et al., 2018; Government of British 
Columbia, 2019). However, the CDG does endorse SMBG as a strategy to identify, monitor and 
prevent hypoglycemia, as well as promote the modification of healthy behaviors or adjust 
medications (Berard et al., 2018). Unfortunately, diabetes self-management behaviors are 
impaired as a result of FI (Essien et al., 2016; Ippolito et al., 2016; Walker et al., 2018). 
Therefore, it remains unclear whether increased SMBG may help prevent hypoglycemia in light 
of impaired capacity for self-management. If individuals are agreeable, willing and able to 
increase SMBG, an individualized strategy could be implemented which assists the individual in 
monitoring their glycemic levels where appropriate, in order to identify periods of hypoglycemia. 
In consideration of the cost of blood glucose strips, PCPs encouraging this strategy should apply 
for additional strips through Pharmacare as per criteria for additional test strips (Government of 
British Columbia, 2019).   
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Theme Two: Hierarchy of Need and Motivation 
 A hierarchy of need and motivation unique to individuals experiencing FI was noted 
throughout the literature. What is concerning amongst individuals with FI is that, unlike their 
food secure counterparts, individuals with FI do not necessarily derive benefit from access to 
comprehensive management by health care providers (Shalowitz et al., 2017). While the 
mechanism is not entirely clear, authors Shalowitz et al. (2017) suggest there are social 
determinants of diabetes control required for the successful management of individuals with FI 
(Shalowitz et al. 2017). Inadequate food, social support and self-efficacy appear to interfere with 
the individual’s capacity to manage his or her diabetes. As a result, these determinants contribute 
to a hierarchy of need, each uniquely influencing an individual’s motivation and ability to 
prioritize diabetes management.  
 When FI is present, eating patterns appear driven by physiological needs (Ippolito et al., 
2016), availability, and accessibility (Essien et al., 2016), rather than a desire for diabetes 
control. These findings highlight the importance of understanding underlying motivators for food 
consumption in the presence of FI, and a hierarchy of eating patterns driven by the level of food 
security. 
  Importantly, stable access to food appears insufficient in supporting adequate self-
management (Ippolito et al., 2016). Social support emerged as an important requisite to diabetes 
management amongst individuals with FI. Individuals with FI experience increased rates of 
depression and distress, but social support appears to act as a buffer against the detrimental 
effects of depression and distress on diabetes self-management (Walker et al., 2018). An 
individual’s perception of consistent support from friends and family (Kollannoor-Samuel et al., 
2011), as well as positive social interactions while engaging in enjoyable activities with others 
73 
 
       
(Walker et al., 2018), was sufficient in mitigating depression and distress symptoms. General 
recommendations for practitioners include assessing for, promoting, and fostering social support 
(Thomas et al., 2018; Walker et al., 2018). 
 Individuals with FI have an overall decreased self-efficacy leading to poorer diabetes 
self-management and A1C control (Gucciardi et al., 2009; Ippolito et al., 2016). The connection 
between FI and decreased self-efficacy remains unclear, however, it is speculated that repeated 
exposure to stress, distress, and depression arising from chronic FI promotes feelings of 
diminished control and self-efficacy (Essien et al., 2016).  
Recommendations for Practice. 
 
 While practical recommendations for managing DM 2 amongst individuals who are food 
insecure were elicited from the literature, it remains unclear whether these recommendations 
may mitigate the hierarchical structure of needs present in individuals experiencing FI. Future 
research should focus on further understanding the relationship between food, social support and 
self-efficacy, and examine whether other needs or social determinants are necessary for effective 
diabetes management amongst individuals experiencing FI.  The role of MTM as an underlying 
mechanism may provide further insight into these relationships and serves as a framework for 
understanding individual motivations and behaviors. 
Theme Three: Food Insecurity Screening  
 
 Screening for FI can be successfully managed and implemented in the healthcare setting, 
and has been found to be both appropriate and acceptable by patients and care providers (De 
Marchis et al., 2019; Thomas et al. 2018). While evidence is limited to one pilot study, FI 
screening has been shown to assist in guiding care, providing support, and bringing meaning and 
understanding to patient self-management behaviors.  
74 
 
       
 A specific and individualized approach for FI screening was preferred over any particular 
screening method (Jones et al., 2013). This individualized approach should include: selecting a 
clear definition of food insecurity useful to the specific purpose, identifying which attributes of 
FI subsequently need to be measured, and finally, selecting a corresponding tool that measures 
these elements (Jones et al., 2013). 
 Selecting a definition of food insecurity. 
 
  There was universal acknowledgement that FI results in interference of proper diabetes 
management and control (Bawadi et al., 2012; Billimek & Sorkin, 2012; Essien et al., 2016; 
Gucciardi et al., 2009; Ippolito et al., 2016; Kollannoor-Samuel et al., 2011; Montgomery et al., 
2017; Shalowitz et al., 2017; Walker et al., 2018). However, few antecedents could be identified 
across various studies. Subsequently, it is unlikely that a universally acceptable definition of FI 
exists. Rather the literature suggests that selecting a definition of FI which corresponds with 
what is intended on being measured is preferred (Jones et al., 2013). For example, the Canadian 
government has operationalized FI screening nationwide, but defines FI as income associated 
(IAFI). They have operationalized this definition in order to identify a specific subpopulation 
experiencing poverty for whom policy changes could be developed to reduce IAFI (Tarasuk et 
al., 2016). How food insecurity is defined in a context sets the tone for how it will be measured 
and identified, what problems are elicited, and which solutions are appropriate. A significant 
limitation to this approach is that the majority of tools presently used measure IAFI, only thus 
validated to measure IAFI (Marques et al., 2015). No singular way to validate a screening tool-
the process is varied depending on what the tool is trying to measure 
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Identifying the attributes. 
 Based on the literature review, there are no comprehensive tools that measure all 
attributes of FI (Ashby et al., 2016; Jones et al., 2013). This is likely in part to a lack of a 
universal definition of FI. Instead, the literature highlighted that successful FI screening requires 
the selection of target attributes intended on being examined (Jones et al., 2013). A focused 
attribute approach prevents the wrong attribute from being measured, confounding attributes 
from interfering with results, irrelevant information from being gathered that does not inform 
management, and identifying attributes of FI that cannot be managed in the healthcare setting 
(Jones et al., 2013). What is problematic with this approach is that the majority of tools are 
validated to measure access to food as a primary attribute for FI (Ashby et al., 2016; Jones et al., 
2013). Future research should examine and develop new tools that measure other important 
attributes particularly important to DM 2 management, such as nutritionally adequate food. 
Screening tool selection. 
 While an individual context-specific approach is favored, several of the most widely used 
tools such as the Household Food Security Scale are only validated to identify and measure IAFI 
and very few other attributes (Marques et al., 2015). Further, Marques et al., (2015) highlight 
that most FI screening tools have not been substantially analyzed or heavily validated (Marques 
et al., 2015). Several consequences may occur if a FI screening method is incorrectly selected: 
(1) the wrong determinant of FI is measured and the information gathered is not pertinent to the 
cause; (2) the tool is validated for the wrong level of data being gathered, i.e. a national FI 
screening tool is selected to identify individual FI; (3) repeat screening of FI is indicated but the 
screening tool selected cannot be used to re-measure FI; and (4) the FI screening tool selected 
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identifies issues beyond available resources for sufficient collection, analysis and intervention 
(Jones et al., 2013). 
 The literature review identified that one screening tool is unlikely to be able to address all 
domains of FI and that FI tools are not universally transferrable across circumstances (Ashby et 
al., 2016; Jones et al., 2013) Further, the majority of the tools have not been substantially 
analyzed (Marques et al., 2015), therefore, selecting a tool appropriate to a healthcare setting 
may be challenging. The recommended approach is to select a tool suited to a particular 
program’s resources (Jones et al., 2013). For example, if practitioners agree to measure access 
and poverty as key attributes to FI, then resources must be in place to support practitioners and 
patients in increasing access to food, and diminishing financial burden.  
Recommendations for Practice. 5 
 Ideally, clinics should identify a definition of FI and corresponding attributes that 
resounds with their patient population and results in the provision of effective management 
strategies. Practitioner limitations and capacity in managing certain attributes of FI should be 
first identified before selecting certain FI tools. While it is important to select tools that are well 
matched to the patient population, ethical issues may arise in identifying aspects of FI that cannot 
be remedied. Additional research is needed to identify how clinics and primary care providers 
operationalize effective identification and screening of FI. 
Limitations and Future Research  
 
 There were several limitations to the integrative literature review findings. They are 
discussed in the following sections: gaps in literature, and other limitations.  
 
                                                          
5 For a list of all available screening tools and their properties, please see Appendix C 
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Gaps in the Literature 
 The majority of FI screening methods available and acceptable for use in the healthcare 
setting are only validated to identify FI secondary to financial constraints. For example, in a 
systematic review examining the validity and acceptability of food insecurity (FI) screening tools 
and their implementation in health care settings, De Marchis et al. (2019) found that all brief 1-3 
question FI screening instruments examined, were all derived from and validated against the 
United States Department of Agriculture-Food Security Survey (USDA-FSS). The USDA-FSS, 
also known as the Household Food Security Survey (HFSS), is the most widely used, accepted 
and validated tool in the United States and other countries, but it is validated only to identify FI 
secondary to financial constraints (Marques et al., 2015). These findings are corroborated by 
Makelarski et al., (2017), who examined the diagnostic accuracy and validity of two other short-
form FI tools used in healthcare; and Ashby et al. (2016) whose systematic review concluded all 
tools function to identify food access issues secondary to financial constraints. What is equally 
problematic is that it is challenging to validate other attributes in FI surveys, because they are so 
varied in what they measure (Jones et al., 2013). Therefore, the scope of these tools is 
significantly narrowed to identify a subpopulation of individuals experiencing FI, and the 
applicability of the tools in practice is significantly limited. Future research should identify or 
establish new screening strategies that identify multiple determinants of food insecurity within 
the healthcare setting. 
 Another limitation regarding the feasibility of implementing FI screening in primary care 
is that the majority of measures or tools have not been rigorously appraised. In a recent 
systematic review examining the psychometric properties of all available household FI measures, 
Marques et al., (2015) found that there was limited appraisal for most tools used. Half of the 
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tools searched had only been tested or appraised in the literature 1-2 times (Marques et al., 
2015). Well-appraised tools were limited to identifying food insecurity secondary to financial 
constraints (Marques et al., 2015). Additional research should critically appraise existing 
screening tools available that have limited research. 
 The literature review supports the integration of FI screening in healthcare settings (De 
Marchis et al., 2019; Thomas et al., 2018). However, the evidence is limited to qualitative 
findings from one study (Thomas et al., 2018) and one systematic review (De Marchis et al., 
2019). A significant limitation of this integrative review is that there is no available literature 
measuring the influence of FI screening on the management of DM 2 (Thomas et al., 2018) to 
support its implementation. While the majority of participating patients and healthcare providers 
supported screening implementation (De Marchis et al., 2019; Thomas et al., 2018), the benefits 
of screening for FI in primary care are inferred and are, at best, speculative in nature.  
 There is a dearth of literature available examining the effects of specific interventions on 
the management of DM 2 in individuals experiencing FI. The present practice recommendations 
are based on the discussion section of cross-sectional studies, one focused literature review, and 
one systematic review. The systematic review offered a limited discussion of the findings. 
Therefore, the strength of findings and recommendations are significantly limited and should, at 
present, be considered suggestions for practice. Several recommendations are based off of the 
Canadian Diabetes Guidelines. Therefore, many of the interventions suggested are based on 
general recommendations for the diabetic population. Future research should directly examine 
the impact of both pharmacological and non-pharmacological interventions on the management 
of DM 2 in individuals experiencing FI. 
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 Other limitations in the literature identified by Jones et al. (2013) include discourse on 
how to establish accurate “cut-offs” for a positive FI screen, and how often to screen for FI 
(Jones et al., 2013). Since the definitions and causes for FI can be so diverse (Jones et al., 2013), 
it remains unclear how implemented tools can integrate accurate cut-offs for identifying FI and 
provide recommendations for repeat screening. Future research should focus on exploring these 
tenets so that PCPs can confidently implement FI screening methods into practice.  
Other Limitations and Considerations 
 An A1C, or glycemic control, is a surrogate marker and its value does not translate into 
absolute risk. However, hard outcomes such as cardiovascular events, mortality and end-organ 
damage require longitudinal studies and extensive funding. As a result, most studies rely on AIC 
as a proxy measure for overall diabetes management. Previous studies caution estimating risk 
using the A1C (Yudkin, Lipska, & Montori, 2011). However, evidence suggests that lowering 
and controlling an A1C remains an important strategy in lowering the risk of micro and 
macrovascular complications (Gorst et al., 2015; Mitsios, Ekinci, Mitsios, Churilov, & Thijs, 
2018; O’Sullivan & Dinneen, 2008; Roussel, Steg, Mohammedi, Marre, & Potier, 2018). To 
establish with certainty whether the current proposed strategies improve the management of DM 
2 in individuals experiencing FI, future research is warranted that measures hard outcomes.  
 Time has been cited as a barrier to FI screening in healthcare by care providers. 
Short form questionnaires (SFQ) can be used readily as they require little time to complete in 
healthcare (De Marchis et al. 2019) and are among the few that have been rigorously analyzed.  
An important trade-off to consider with SFQ are simplicity and comparability over the 
comprehensive and contextual detail of longer questionnaires (Jones et al. 2013). Lastly, it is 
important to note that most SFQ are validated to measure almost exclusively FI secondary to 
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financial constraints (Ashby et al., 2016a; Makelarski et al., 2017; Marques et al., 2015). Future 
research should explore primary care providers’ experiences of time constraints and establish 
acceptable time-appropriate strategies for identifying more diverse forms of FI.  
 Research is lacking into how PCPs can best use the hierarchy of needs and motivations 
identified in the literature to support and develop an individualized self-management plan 
cognizant of a patient’s capacities and motivations for behavior. Future research should examine 
the perspectives and lived experiences of individuals with DM 2 and FI, which may help elicit 
further detail about underlying needs and motivations, and viable management strategies.  
Conclusion 
 The relationship between FI and DM 2 is complex. FI has profound effects on the 
management of DM 2 but is difficult to identify, presenting a challenge for providers in 
managing DM 2 in individuals experiencing FI. The harmful effects of poorly managed diabetes 
secondary to FI emphasize the importance of identifying FI to enhance the management of, and 
to prevent complications associated with, DM 2.  
 This integrative review examined how NPs can use FI screening in primary care to 
enhance the management of individuals with DM 2 experiencing FI. A comprehensive literature 
search highlighted relevant articles. Fifteen articles in total were selected for final review. The 
selected articles were analyzed and the findings provided insight into how screening can be most 
effective in identifying FI, and which management strategies in primary care may be most 
effective for individuals with DM 2.  
 A synthesis of the findings from this review highlighted the importance of understanding 
the influence of FI on food behaviors, mental health, and medication use. Through the support of 
Maslow’s Theory of Motivation (MTM), a better understanding was achieved with respect to 
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motivations for behavior and diabetes self-management amongst individuals with FI. Key 
findings from the literature review highlighted how FI reduces one’s relationship to food to basic 
physiological need, superseding their capacity to use food for the dietary management of DM 2. 
As a result, compensatory food behaviors develop that are destructive to glycemic control. While 
efforts to supply stable food through low-cost alternatives or food banks are important, this 
strategy alone is not sufficient. Strategies to manage FI-mediated changes in food behaviors 
include individualized nutrition approaches cognizant of an individual’s personal limitations, 
assessments for the risk and occurrence of hypoglycemia, and consideration of referrals to social 
work and dieticians for additional support.  
 Another key theme was the influence of FI on mental health and the subsequent 
challenges it presented in managing DM 2. The literature revealed that FI created a persistent 
level of stress, depression and distress, ultimately affecting an individual’s capacity to engage in 
self-care behaviors such as healthy eating, exercising, and self-monitoring of blood glucose, 
which ultimately influenced the level of glycemic control. Furthermore, there was evidence that 
distress and depression resulted in an increase of some unhealthy behaviors such as smoking. 
This relationship appeared to be mitigated by social support. In particular, the presence of 
informal social support of friends and family in social contexts was particularly effective at 
mitigating depression. Strategies to manage the influence of mental health on the management of 
DM 2 include assessing an individual’s level of social support, providing referrals or resources if 
necessary and creating a patient centered treatment strategy that acknowledges the individual’s 
mental health and their capacity to self-manage their diabetes. Lastly, the findings also indicated 
that particular attention should be paid when financial constraints underlie FI, as this 
82 
 
       
subpopulation appears to suffer additional consequences and experience additional stressors 
hampering their ability to self-manage their diabetes. 
 FI screening in primary care is both feasible and acceptable. At present, there exists no 
comprehensive FI tools capturing all attributes of FI. Instead, the literature review suggests: (a) 
carefully examining the population of interest, available resources and feasible interventions; (b) 
selecting a definition and attributes of FI that reflect these key components; and (c) selecting a 
screening tool validated to capture these attributes. Challenges in this process were also 
identified. Several reviews indicated that, despite a diversity in FI conceptualization, the majority 
of tools were only validated to measure food access secondary to financial constraints, and that 
the majority of available tools also lacked rigorous appraisal.  
 Recommendations for future research were also identified in this integrative review. 
Additional research should establish validated strategies that identify multiple attributes of FI 
within the healthcare setting. Although the literature indicated that identifying FI in healthcare 
may be feasible and appropriate, FI identification methods are almost exclusively limited to 
identify FI secondary to financial constraints. Further, there is a dearth of literature examining 
whether FI screening improves the management of DM 2. Similarly, no studies to date have 
examined the benefit of specific interventions on the management of DM 2. Future research 
should examine how FI screening directly benefits the management of DM 2 in primary care and 
which interventions provide the most benefit. Additionally, few articles examined the 
perspectives of individuals with DM 2 experiencing FI.  
 While a hierarchy of needs and underlying motivations for behavior were identified in the 
literature, there is a lack of research into how PCPs can best use this knowledge to support 
individuals with DM 2 experiencing FI, and how to develop an individualized self-management 
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plan, cognoscente of a patient’s capacities and motivations for behavior. These areas for future 
research which help support PCPs in how best to identify FI in the PC setting and to enhance the 
care they provide to individuals with DM 2 experiencing FI. 
 This integrative review highlighted how NPs as PCPs can play influential roles in  
screening for FI and managing DM 2 among individuals with FI. The literature findings 
highlight how PCPs can be key in identifying FI among their patients based on the trust and 
rapport that develops. Further, NPs are undertaking difficult conversations with patients 
surrounding the more vulnerable aspects of FI such as unhealthy food behaviors, stress, 
depression and medication adherence. NPs are also managing pharmacological and non-
pharmacological aspects of care, considering the social determinants of health, including food 
insecurity, when providing care.  
 As the incidence and prevalence of DM 2 in Canada is projected to increase and FI 
remains pervasive in our Canadian population NPs must strive to identify the unique struggles of 
this subpopulation in primary care. The findings of this integrative literature review highlight 
how FI influences the management of DM 2. By screening for FI in primary care, the findings of 
this review can support NPs in identifying individuals with DM 2 experiencing FI. Ultimately, 
the findings assist NPs better managing DM 2 and glycemic control amongst individuals who are 
food insecure and contribute to the work in preventing diabetic complications. 
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hospital and to 
investigate its 
relation to 
glycemic 
control. 
Cross-sectional 
design 
 
843 patients (327 
male and 516 
female) between 
22-84 years old 
with confirmed 
diagnosis of type 2 
diabetes who were 
patients in the 
endocrinology 
clinic at King 
Abdullah 
University 
Hospital (KAUH) 
in Al-Ramtha. 
 
Northern Jordan  
Definition of FI used: 
“food insecurity is 
defined as limited or 
uncertain 
availability of 
nutritionally adequate 
and safe foods in 
socially 
acceptable ways” 
 
Interview-based 
questionnaire used to 
gather socioeconomic 
and health data  
 
Weight and height  
measured by a trained 
nutritionist.  
 
food frequency 
questionnaire (FFQ) 
used for dietary 
assessment. 
 
food processor 
software used to 
process dietary data.  
 
Short form of the U.S. 
food security survey 
used to identify FI  
 
Food insecurity 
categorized as 
moderately food 
insecure (MFIS) and 
severely food 
(1) gender, age, education, 
and income are all related to food 
security status 
 
(2) Glycemic control worse in 
MFIS and SFIS 
 
(3) 70% of SFIS stated they often 
could not afford to eat a balanced 
meal.  
 
(4) 99% of the SFIS run out of food 
by the end of the month, and either 
meal skip, or cut meal size as a 
compensatory mechanism for 
running out of food.   
 
(5) SFIS associated with 
significantly higher average body 
mass index (2 BMI units) 
 
(6) No difference in overall intake 
of calories between all groups but 
SFIS consumed more sugar, on 
average, than MFIS and FS 
counterparts 
 
Strengths  
 
Previous studies confirm that the 
US short-form questionnaire has 
been validated to be used in 
developing countries 
 
FFQ locally validated by asking 
20 volunteer diabetic patients to 
review and with multiple day 
diaries.  
200 Jordanian-specific items 
were added 
 
Limitations 
 
No power calculation  
 
Food frequency questionnaires 
are not 100% correlative with 
true diets  
 
Important covariates not 
controlled for:  
alcohol intake and smoking 
. 
Difficult to generalize based on 
Jordanian population, food costs, 
economical circumstances 
 
Self-report creates recall bias 
 
Cross-sectional surveys cannot 
determine causality  
 
The general questionnaire was 
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insecure (SFIS) using 
standardized protocol 
 
Glycosylated 
hemoglobin (HbA1c) 
used to measure 
glycemic control  
 
Chi-square, and post-
hoc analysis of 
variance was used as to 
analyze the data 
not standardized or validated. It 
was developed by the research 
team  
 
Selection bias:  
 screening patients in 
hospital versus diabetics in 
general population seeking 
primary care  
 
CASP Rating: 
Moderate/low 
 
Authors, Date 
& Title 
Aim Study Design,  
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Bilimek & 
Sorkin, (2012) 
 
Food 
Insecurity, 
Processes of 
Care, and 
Self-Reported 
Medication 
Underuse in 
Patients with 
Type 2 
Diabetes: 
Results 
from the 
California 
Health 
Interview 
Survey 
To establish 
whether there is 
an independent 
association of 
food insecurity 
to processes of 
care or delays 
in filling 
prescriptions 
Cross sectional 
design 
 
N = 3,401 
Adults selected 
from the 2007 
Public Use File of 
the California 
Health Interview 
Survey (CHIS), (a 
randomized 
process) and  
(1) had a diagnosis 
of type 2 diabetes 
(2) saw a care 
provider over the 
last year (3) were 
presently taking 
diabetes 
medications  
 
California 
Multivariable logistic 
regression analyses that 
adjusted for age, 
gender, education, 
race/ethnicity, factors 
related to access to 
care: insurance status, 
number of visits to the 
doctor in the previous 
year, and access to an 
automobile), duration 
of diabetes, general 
health condition, and 
psychological distress. 
  
Process of care defined 
by completing 
hemoglobin A1c, a 
dilated eye exam, 
and a foot exam over 
the last year 
 
(1) Individuals with food insecurity 
are significantly more likely not to 
fill their prescriptions even when 
other variables are adjusted for 
 
(2) food insecurity may 
independently interfere with 
optimal diabetes management  
 
(3) Food insecurity does not 
interfere with process of care 
 
 
Strengths  
Multivariable logistic regression 
analyses adjusted for several 
factors 
 
Limitations 
 
How FI is defined creates 
classification bias 
-Assumes below poverty line are 
the only people with food 
insecurity. Does not take into 
account other reasons for not 
being ale to afford medications. 
 
Does not address other 
medication behaviors connected 
with food 
insecurity such as medication 
underuse  
skipping doses, and 
discontinuing medications 
 
Does not measure power 
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Timing of prescription 
pick up measured 
using:  
(1) the Medication 
Expenditures Panel 
Survey (Agency for 
Healthcare 
Research and Quality 
[AHRQ] 2004) and a 
questionnaire asking 
about the nature of 
delays in filling scripts  
 
Binary scoring used to 
determine the presence 
of food insecurity 
amongst individuals 
with household income 
less than 200 percent of 
the federal poverty 
level. 
 
Possible selection bias only 
including individuals with 
diabetes who had sought 
healthcare in the last year.  
 
Generalizability limited due to 
population 
 
Recall bias possible in 
questionnaire. 
 
Observational studies don’t 
provide robust enough evidence 
to recommend changes to 
clinical practice 
 
No power measure 
 
CASP rating: Moderate 
quality 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Gucciardi,  
Vogt, Demelo,  
& Stewart  
(2009) 
 
Exploration of 
the 
Relationship 
Between 
Household 
Food Insecurity 
and Diabetes in 
Canada 
 
(1) determine 
the 
prevalence of 
food insecurity 
amongst 
Canadians with 
diabetes  
(2) 
examine the 
relationship 
between food 
insecurity  
and diabetes 
management 
Cross-sectional 
design 
 
N= 2,523 
Ontarians to 
examine the 
relationship of FI 
to management, 
health status, and 
self-care 
(management) 
practices  
 
N= 6, 237 from 
throughout Canada 
to examine the 
Definition of food 
insecurity: “exists 
when all people, at all 
times, have physical 
and economic access to 
sufficient, safe, and 
nutritious food to meet 
their dietary needs and 
food preferences for an 
active and healthy life”  
 
Data was analyzed 
from 
 A Canadian-validated 
survey (2005 Canadian 
Community Health 
(1) Process of care  
was the same in individuals with 
food insecurity and food security  
 
(2) Individuals with diabetes who 
are food insecure are more likely to 
be physically inactive, be 
overweight, eat less fruits and 
vegetables, twice as likely to be a 
smoker, twice as likely to report 
stress, report lower general health, 
mental health and perceived stress 
 
(3) No impact on accessing medical 
care. 
 
Strengths  
 
OR=Results appear clinically 
significant 
 
HFSS and CCHS are Canadian 
validated surveys 
 
Limitations 
 
No p-values provided  
 
How FI is defined creates 
classification bias 
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prevalence of food 
insecurity in 
individuals with 
type 2 diabetes 
versus the rest of 
Canada.   
 
Canada  
Survey [CCHS]) was 
used to compare 
 the prevalence of food 
insecurity in Canada 
compared to the 
prevalence of FI 
Canadians with 
diabetes. 
 
Ontario CCHS surveys 
contained both FI and 
diabetes modules and 
were used to examine 
the relationship 
between food 
insecurity  
self-care and 
management and health 
status. 
 
Used Canadian-
validated Household 
Food Security Survey 
(HFSS) 
to identify income-
associated food 
insecurity   
 
Process of care 
measured by 
completing hemoglobin 
A1c, a dilated eye 
exam, a urinalysis  
and a foot exam over 
the last year and taking 
ASA and cholesterol 
medication 
 Cross sectional analysis-difficult 
to draw causational relationships 
 
Only Ontario examined for the 
impact of FI on diabetes and 
some populations were excluded 
e.g. First Nations. i.e. 
Possibly not generalizable to all 
of the Canadian population, or 
may result in an information bias 
 
Cannot generalize that overall 
diabetes management is is 
similar for FI and food secure 
counterparts based on the study’s 
specific identifiers.  
 
Ontario coverage may influence 
generalizability of results of 
SMBG and medication 
adherence 
 
Possible measurement bias: 
Surveys any missing information 
on diabetes or food insecurity 
were excluded  
 
Questionnaires are subject to 
recall bias 
 
Questionnaire not validated to 
identify difference between DM 
1, DM 2 and gestational. 
 
No power calculation  
 
CASP rating:  
Moderate-low 
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Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Ippolito, Lyles, 
Prendergast, 
Marshall, 
Waxman5 & 
Seligman 
(2016) 
 
Food insecurity 
and diabetes 
self-
management 
among food 
pantry clients 
 
 
To observe the 
association 
between food 
security (FI) 
and diabetes 
self-
management of 
patients 
accessing food 
pantries 
 
Cross-sectional 
design  
 
Adults with 
diagnosed diabetes 
(via HbA1C or 
self-report) 
 
Using diabetes 
medications  
 
Speak English or 
Spanish  
 
accessing 
designated food 
pantries 
 
Sonoma County, 
Columbus, & 
Corpus Christi, 
USA 
Food insecurity defined 
as “limited or uncertain 
access to adequate food 
at the level of the 
household related to 
affordability   
 
Baseline surveys for 
diabetes self-
management 
intervention completed 
between  
March 2012 and March 
2014.  
 
Food insecurity 
determined using short 
form of the US 
Department of 
Agriculture’s 
Household 
Food Security Survey 
Module (HFSSM) 
which measured 
income-associated food 
insecurity. Three 
groups identified using 
questionnaire: food 
secure, low food 
secure, very low food 
secure 
 
8 indicators of diabetes 
self-management 
examined: 
Very low food secure participants 
had  
 inferior diabetes self-efficacy 
 more medication non-
adherence 
 more frequent severe 
hypoglycaemic episodes 
 
Low food secure and very low food 
secure both had 
 Increased prevalence of 
depression and distress 
 Greater issues affording 
medication  
 More food- medicine-health 
supply trade-offs. 
 
No statistically significant 
difference in mean 
HbA1c (Table 1) or percentage of 
participants with HbA1c 
level above 8·5% 
 
Tobacco use was more than twice 
as frequent in the very 
low-food-secure compared with the 
food-secure group 
 
dose–response relationship between 
severity of food insecurity and 
barriers to diabetes self-
management. 
Strengths 
 
Demonstrates strong statistical 
significance 
 
OR indicates strong clinical 
significance  
 
Validated questionnaires used 
 
83% response rate  
 
Limitations 
 
Categories used for Low food 
security and very low food 
security were decided by 
convention  
 
Cross sectional-cannot determine 
causality 
 
Control group significantly 
smaller than cases 
 
Recall bias with questionnaire 
 
Potential selection bias: 
 How FI is defined 
 by selecting participants 
accessing food pantry only  
 food secure controls are 
accessing food bank 
 not enough “controls” or 
food secure individuals 
comparatively speaking 
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(1) HbA1c; (2) diabetes 
self-efficacy; (3) 
diabetes 
distress; (4) medication 
non-adherence; (5) 
severe hypoglycaemia; 
(6) depressive 
symptoms; (7) 
medication 
affordability; and (8) 
food–medicine 
purchasing trade-offs. 
 
HB A1C used to 
measure diabetes 
control 
 
Self-efficacy measured 
using 8-item 
questionnaire; diabetes 
distress measured using 
2-item questionnaire;  
Medication adherence 
 measures using a four-
item Medication 
Adherence 
Questionnaire; 
Severe hypoglycemia 
assessed by asking “In 
the past 4 weeks, how 
many times have 
you had a severe low 
blood sugar reaction, 
such as passing 
out or needing help to 
treat the reaction?’ 
Depressive symptoms 
assessed using patient 
Health Questionnaire-
2; 
Difficult to generalize some 
results from United States: 
 Medication and supply costs 
in California unique creating 
unique medicine-health 
supply-food trade offs 
 Medicine costs and 
coverage based on insurance 
affect affordability in a way 
unique to California and the 
individual 
 
Cannot control for all potential 
confounders, including medical 
co-morbidities 
 
Possible information bias: some 
interviews done in person and 
some over the phone 
 
CASP rating: 
High 
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Inability to afford 
medicine was assessed 
by asking:  
‘In the last 12 months, 
how often did you take 
less medicine than you 
were supposed to 
because you could not 
afford to buy more?’ 
Medicine-food trade 
offs were assessed 
using a 4-point 
questionnaire. 
 
Five covariates were 
measured and 
controlled for: age, 
gender, race/ethnicity, 
education and study 
site 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Kollannoor-
Samuel, 
Wagner, 
Damio, Segura-
Pe´rez, 
Chhabra, Vega-
Lo´pez, & 
Pe´rez-
Escamilla 
(2011) 
 
Social Support 
Modifies the 
Association 
Between 
Household 
Food 
Identify risk 
factors for 
depression 
amongst 
individuals who 
are food 
insecure and 
establish if 
social support 
mediates this 
risk  
 
 
Cross sectional  
 
211 low income 
Latino 
adults with T2D 
 
Connecticut 
Definition: “Limited 
availability, access 
and/or 
intake of nutritionally 
adequate foods”  
 
Baseline data form 
DIALBEST trial 
(longitudinal RCT) 
used. 
 
Participants were 
(1) 21 years old (2) 
living in Hartford 
County, CT, (3)  
HbA1c >7%, and (4) 
no medical conditions 
At each level of food insecurity, 
greater social support led to lower 
depression rates 
support  
 
Results suggest  
Social support buffers depression 
risk in individuals experiencing 
food insecurity  
 
 
Increased depressive symptoms 
associated with: 
 lower household income,  
 increased perceived 
interference of DM2 on life 
Strengths 
Validated tool for depression in 
DM2 
 
Covariates known to be 
associated with depression were 
included in multivariate analysis 
 
Limitations  
Cross sectional analysis 
 
Cannot control for underlying 
genetic predisposition for 
depression or pre-existing traits  
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Insecurity and 
Depression 
Among Latinos 
with 
Uncontrolled 
Type 2 
Diabetes 
completely limiting 
physical activity. 
 
Depressive symptoms 
measured using the 
Center for 
Epidemiologic Studies 
(CES-D) Scale 
 
Food insecurity 
measured using Short 
form of the US 
household food 
security supplement 
module [US-HFSSM]  
 
Social support 
measured using an 11 
item-questionnaire 
Multi Dimensional 
Diabetes Questionnaire 
 
Cultural, clinical, 
psychosocial variables 
measured using 
validated tools.  
 
Multivariate logistic 
regression model used  
 
Logistic regression 
used to determine 
social support-food 
insecurity-depression 
interaction  
 Increased diabetes related 
clinical symptoms 
 
 
Our study suggests that depression 
risk is associated 
with the perception of how much 
diabetes interferes with 
work, income generation, 
relationship with partner, daily 
routine activities, and/or social 
activities 
 
Increasing social capital for patients 
with DM2 who are food insecure 
may mediate depressive symptoms-
especially amongst individuals in 
low SES. 
Limited generalizability: Puerto 
Rican & predominantly female 
participants 
 
Perceived social support limited 
by recall bias  
 
Post hoc- alpha Cronbach 
demonstrates internal 
consistency to support reliability 
of surveys used 
 
CASP rating 
Low 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Shalowitz, Eng, 
McKinney, 
Determine if 
food insecurity 
longitudinal 
observational study 
comprehensive care, 
including complete 
Insulin use and A1C increase with 
increasing food insecurity.  
Strengths  
Longitudinal study 
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Krohn, Lapin, 
Wang & 
Nodine (2017) 
 
Food security is 
related to adult 
type 2 diabetes 
control over 
time in a 
United States 
safety net 
primary care 
clinic 
population 
(FI) is 
associated 
longitudinally 
with poor 
glucose control-
even when 
barriers to 
comprehensive 
management 
are minimized.  
 
 
336 patients from a 
multi-site federally 
qualified health 
centre (FQHC) 
servicing 
individuals with 
DM2 
 
Illinois 
medication 
management is 
provided to  
Individuals with DM2: 
 Medication and 
testing supply 
assistance 
 Diabetes self-
management 
 Education 
 One-on-one and 
group support 
 Retinal screenings 
 Fitness 
 programmes. 
 
Data collected using 
 baseline 
assessment of 
patients’ FI 
using the short form 
US Household Food 
Security Module 
follow up screening FI 
annually and after 
study completion  
 
A1C levels recorded 
throughout 24- month 
study period (between 
2-6 times depending on 
participant) and once 
during follow up. 
 
longitudinal mixed-
effects models using  
 maximum 
likelihood 
estimating method  
 
level of FI only slightly related to 
BMI 
 
low food security directly impacts 
glucose control  
 
Unlike individuals who are FS, 
individuals with FI do not derive 
benefit from  
access to comprehensive 
management (comprehensive care 
included quarterly visits with A1C 
testing, 
medication and testing supply 
assistance, diabetes self-
management education, one-on-one 
and group support, retinal 
screenings, and fitness 
programmes). 
 
Directly supports the significance 
of the social determinants of 
diabetes control 
 
Near independent effect of FI on 
diabetes control, confirmed with 
multivariable model 
 
Validated tool used for FI 
 
Limitations 
Generalizability limited:  
 Results based on one 
facility. 
 Culturally limited to African 
Americans, Hispanic, and 
Caucasian  
 
No power calculation  
 
CASP rating 
Moderate 
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 unstructured 
covariance 
controlling  
 covariate analysis 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
De Marchis; 
Torres; 
Fichtenberg; 
& Gottlieb 
(2019) 
Identifying 
Food Insecurity 
in Health Care 
Settings: A 
Systematic 
Scoping Review 
of the Evidence  
Examine the 
validity and 
acceptability of 
food insecurity 
(FI) screening 
tools, and their 
implementation 
in health care 
settings. 
Systematic review 
 
25 articles 
 
United States 
 
 
PubMed and Ovid 
MEDLINE were 
searched using 
keywords from 3 
domains: (1) FI; (2) 
screening; and (3) 
health care settings 
Between June 30th, 
2000- 
July 27, 2017. 
 
Articles excluded if 
evidence for validity, 
acceptability, or 
feasibility of FI 
screening not included  
 
What was examined: 
study design and 
setting; FI screening 
tools; barriers to 
uptake; patient vs 
clinician factors, FI 
appropriateness, 
acceptability, or 
feasibility 
 
Studies were assigned 
quality ratings using 
the Grading 
Recommendations 
Assessment 
Development and 
Majority of articles conducted in 
pediatric setting  
 
Brief FI screening instruments were 
all derived from and validated 
against the United States 
Department of Agriculture-Food 
Security Survey (USDA-FSS) 
 
Brief (1- and 2-item) FI screening 
tools are validated for use in US 
healthcare settings, mostly among 
caregivers in pediatric population 
 1-item hunger screening 
question 
 SEEK (safe environment 
for every kid) 
 2-item Hunger Vital Sign 
 
no difference in screening mode of 
administration (based on one RCT) 
 
66% -88% found it appropriate to 
be asked about FI in healthcare 
setting (based on 6 observational 
studies of low quality of caregivers 
for pediatric patients and young 
adults) 
 
between 80-89% of clinicians found 
it acceptable to screen for FI in 
healthcare visits (based on 2 
Strengths 
Covers several aspects regarding 
the implementation of FI 
screening 
 
Each article was assigned a 
quality rating  
 
Each finding listed the number 
of articles and level of quality it 
was based on.  
 
Limitations 
Validated against USDA Food 
security scale  
 Limited generalizability  
 USDA-FSS is limited to 
financially associated food 
insecurity. 
 
Limited mostly to pediatric, 
young adult population  
 
Some conclusions were derived 
from only 3-4 studies. 
 
19 of 25 studies examined were 
rated low-very low quality.  
 
CASP grade 
Moderate 
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Evaluation approach 
(GRADE) 
 
Standardized mean 
differences were 
calculated using 2-by-2 
frequency tables of 
outcome frequencies  
qualitative articles of very low 
quality) 
 
time required for FI screening was 
varied (30 seconds to 10 minutes)  
 
4 out of 10 studies reported time as 
a barrier to FI screening in practice 
while 6 out of 10 reported time 
created minimal barriers to 
implementation (all observational 
studies)  
 
6 articles found that educating on 
the importance of FI screening and 
impact of SDOH on patient health 
improved FI screening competence 
and uptake 
 
Not everyone who screens positive 
for food insecurity wants help from 
care providers 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Jones, Ngure, 
Pelto & Young 
(2013) 
 
What Are We 
Assessing When 
We Measure 
Food 
Security? A 
Compendium 
and Review 
of Current 
Metrics 
 
 
1) examine 
food security 
(FS) as a 
concept, the 
different 
methods used to 
measure FS 
along with their 
purpose and 
concepts of FS 
used   
 
2) Identify 
challenges to 
FS 
Review  
 
17 different FS 
measures  
 
Total sample 
unknown, 17 
articles pulled as 
part of screening 
for validation in its 
use for FS 
 
No restrictions on 
location  
PubMed, CABI, 
Elsevier, Google 
Scholar, and Web 
of Science as well as 
the Web sites of 
several international 
organizations 
 
Included Screening 
tools, metrics (proxy 
measures) or any 
method historically 
correlated with FS. 
Concept of food security: having 
consistent and stable, physical and 
financial access and availability of 
nutritionally adequate food and the 
ability to utilize, acquire and 
consume food in socially and 
culturally acceptable ways 
 
Access needs to be further broken 
down and understood as 3 different 
aspects: access, acquisition, and 
consumption 
 
Food measures are not always clear 
about what concepts of FS they are 
Strengths 
 
Assessed the individual quality 
and strength/limitations of each 
FS measure 
 
Examine 17 different food 
security measures 
 
Limitations 
 
CI and p-values provided for 
validation measures only 
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measurement 
and future 
directions 
needed  
measuring, nor do they all have the 
same purpose  
 
Challenges to measuring food 
insecurity  
1) accurately measuring dietary 
sufficiency 
2) Determining which concepts of 
FS the measurement aims to 
address 
3) discerning between various 
components of food access 
3) accurate cutoff for food 
insecurity 
 4)  controlling for  
Response and recall bias  
6) validating measures when they 
are so diverse in what they measure 
 
One is not necessarily superior: 
rather it is important to choose  
A screening tool that is informed 
by the concept that one intends to 
measure.  
 
Data across measures collected at 
differing levels (national, regional, 
household, and/or individual 
Levels) 
 
Acquiring foods in socially 
acceptable/unacceptable ways is not 
measured 
 
Safety of food acquired is not 
measured 
 
Nutritionally adequate diet/diet 
quality not measured 
 
Individual articles are not 
assessed for their quality  
 
Unclear how information or 
findings were grouped as based 
on what level of evidence. 
 
CASP rating 
Low 
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Difficult to identify chronic, vs 
transitory vs seasonal food 
insecurity 
 
Important trade-off to consider with 
selecting food security screening 
tools: exchanging  
comprehensibility and contextual 
detail for simplicity 
and comparability 
 
No singular way to validate a 
screening tool-the process is varied 
depending on what the tool is trying 
to measure. 
 
One metric is unlikely to be able to 
address all domains of FS.  
Consider selecting FS measures that 
identify aspects that can be 
addressed or is suited to a particular 
program’s resources 
 
Household consumption and 
expenditure surveys or dietary 
diversity surveys may be best in 
identifying household level 
behaviors, however there is a lot of 
room for error.  
 
 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Ashby, Kleve, 
McKechnie, & 
Palermo (2016) 
 
Measurement 
of the 
Identify and 
review all 
multi-item tools 
measuring food 
insecurity (FI) 
available in 
Systematic Review 
 
13 articles  
 
All developed 
countries 
CENTRAL, CINAHL 
plus, EMBASE, 
MEDLINE, TRIP were 
searched 
 
8 tools were identified in total  
 
All tools assessed food access as a 
dimension and it is addressed 
adequately in each tool.  
 
Strengths 
quality of the study 
and risk of bias for every study is 
assessed 
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dimensions of 
food insecurity 
in developed 
countries: a 
systematic 
literature 
review 
developed 
countries and 
explore the 
dimensions of 
FI they address. 
English studies since 
1999.  
 
USDA Food Security 
Survey Module 
excluded due to the 
known 
reliability/validity 
established in earlier 
(Marques et al. (2014) 
systematic reviews. 
 
Data were summarized 
against the dimensions 
of food insecurity  
 
quality of the study 
and risk of bias as 
assessed using the 
American Dietetic 
Association Evidence 
Analysis Manual 
 
 
Most tools only assessed food 
access as a dimension 
 physical and economic 
resources to access food 
 
Tools do not explore other 
components of FI.  
 
Radimer/Cornell tool enquired 
about anxiety 
around eating a good meal due to 
assistance required 
with preparing food, and food 
utilization 
 
Kuyper tool attempted 
to measure stability over time 
 
Only one tool measures both 
household food insecurity, and 
individual food insecurity  
 
All studies used Cronbach’s alpha 
(coefficient of 
internal consistency) to measure 
reliability and scored moderate to 
high. 
 
All tools are self-report 
Discussed each measurement’s 
reliability and validity  
 
Limitations  
None  
 
CASP rating  
High 
 
Authors, Date 
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Marques, 
Reichenheim, 
de Moraes, 
Antunes, & 
Salles-Costa 
(2014) 
 
Identify & 
describe 
household food 
security scales 
available in 
peer reviewed 
literature and 
examine, plus 
Systematic review 
 
24 different tools 
from 184 articles 
written either in 
English, Spanish or 
Portuguese 
 
Databases used: 
MEDLINE, LILACS 
and SciELO databases,  
 
Terms used: (‘food 
insecurity’ OR ‘food 
security’) AND 
Instruments use different terms to 
describe same concept of household 
food insecurity 
 
All instruments or tools were 
developed using the same 
underlying concept of food 
insecurity (FI): poor access to food 
Strengths 
Minimized publication bias by 
examining  
the reference sections of all the 
articles to ensure articles weren’t 
missed using the algorithm-
based search method 
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Household food 
insecurity: a 
systematic 
review of the 
measuring 
instruments 
used in 
epidemiological 
studies 
 
 
synthesize their 
psychometric 
properties. 
Tools developed in 
United States  
Canada, 
Venezuela, 
Colombia, Costa 
Rica,  
Burkina Faso, 
Kenya, Iran, 
Bangladesh  and 
Indonesia 
(‘questionnaires’ OR 
‘scales’ 
OR ‘validity’ OR 
‘reliability’) 
 
No time period limit 
applied 
 
Use household food 
insecurity (HFI), not 
individual food 
insecurity 
 
Article review carried 
out by independent 
reviewers 
 
Reliability was 
classified by using 
intra-observer  
reliability, inter-
observer reliability and 
internal 
consistency  
 
Validity: examined for  
(i) face or content 
validity 
(ii) structural 
(dimensional) 
Validity 
(iii) criterion or 
concurrent validity 
(iv) construct 
Validity 
 
Tools were only 
included if they 
contained 3 or items. 
secondary to financial constraints. 
Other underlying aspects of FI 
unexplored 
 
For most tools there is very limited 
appraisal  
 
Core Food Security 
Measurement/Household Food 
Security Survey Module 
(CFSM/HFSSM) has been 
significantly analyzed in literature, 
while SPHFSS and HFSSM-6SF 
have been moderately analyzed in 
the literature. Half of the tools had 
only been tested or studied in the 
literature 1-2 times. 
 
CFSM/HFSSM and HFSSM-6SF 
studied/validated in 
many countries worldwide 
 
Cronbach’s α coefficients 
demonstrates good internal 
consistency for CFSM/HFSSMand 
HFSSM-6SF  
& SPHFSS with α 
varying from 0·82 to 0·94. 
 
Few studies measured other 
Dimensions of reliability e.g. test–
retest reliability 
 
All 3 had studies that measured 
construct validity, structural 
validity, convergent validity  
 
Most tools examined only 
reliability and validity Future 
studies should aim to examine other 
Limitations 
Tools with less than 3 items 
were not included 
 
Language bias 
 
Selection bias: FI tools not 
previously part of a peer 
reviewed study not included  
 
 
Casp Rating  
High 
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psychometric properties not yet 
explored 
 
HFSSM-6SF has demonstrated 
acceptable screening capability in 2 
validity studies 
 
Choosing an appropriate instrument 
for use requires significant in-depth 
analysis, but to date has not been 
done in the majority of the tools 
measuring FI 
 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Makelarski, 
Abramsohn, 
Benjamin, Du, 
& Lindau 
(2017) 
 
Diagnostic 
Accuracy of 
Two Food 
Insecurity 
Screeners 
Recommended 
for Use in 
Health Care 
Settings 
To test the 
diagnostic 
accuracy of the 
American 
Academy of 
Pediatrics 
(AAP) and 
Hunger Vital 
Sign (HVS) 
against gold 
standard 
Household 
Food 
Security Screen 
short form 
(HFSS-sf) 
Case control  
 
N= 342 
patients,  
parents, caregivers, 
family 
members, and 
friends of patients 
>18 years of age 
 
Emergencies 
Chicago Illinois 
between July-Nov 
2016 
Definition used: 
“limited 
or uncertain 
availability of 
nutritionally adequate 
and safe foods” 
 
A self-administered 
survey was given 
which included all 3 
tools. Approximately 
half the participants 
completed based on a 
30-day recall and the 
other half with a 12-
month recall. 
 
Sensitivity specificity,  
positive likelihood 
ratios, negative 
likelihood ratios and 
95% confidence 
intervals (CIs) were 
calculated 
Compared to gold standard (HFSS), 
the AAP lacks sensitivity: Nearly 
25% of individuals who positively 
identified with FI through HFSS, 
were negative with the AAP. 
 
AAP tool slightly more sensitive 
amongst households with children 
compared to without children 
 
HVS was highly sensitive in 
detecting FI compared to HFSS-sf, 
but has lower specificity than AAP. 
 
HVS viable alternative to HFSS-sf, 
however AAP is lacking sensitivity 
 
Yes or no i.e. dichotomous surveys 
for FI might be prone to more 
measurement error than surveys 
with more response options. 
 
Stigmatization may play a role in 
answers and survey accuracy- 
Strengths 
No priming effect noted based 
on the order screening tools were 
employed.  
 
High response level 
 
Valid results 
 
Limitations 
Statistically significant results 
had wide confidence intervals, 
lack precision.  
 
Small sample size. Lacks power 
to identify small differences 
 
Selection bias-people who were 
unwell were excluded 
 
Recall bias with self 
questionnaires 
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 answering “yes” is more 
stigmatizing than “sometimes true” 
 
 
Measurement bias-some surveys 
had missing data 
 
Generalizability- 76% African 
American respondents from one 
hospital in Chicago 
 
Using HFSS-sf as gold standard. 
It is not absolute in detecting all 
forms of FI.  
 
Possible social desirability bias-
easier to say “sometimes true” 
than to answer “yes” to FI. 
 
Some mention of, but no 
adjustment for confounding 
factors 
 
CASP rating 
Low 
Authors, Date 
& Title 
Aim Study Design, 
Sample & 
Location 
Methods & Analysis Key Findings: Strengths & Limitations 
Thomas, 
Fitzpatrick, 
Sidani, & 
Gucciardi 
(2018) 
 
Developing and 
Implementing a 
Food Insecurity 
Screening 
Initiative for 
Adult Patients 
Living With 
Type 2 
Diabetes 
Examine 
acceptability & 
feasibility of a 
food insecurity 
(FI) screening 
initiative that 
will help health 
providers 
modify diabetes 
management 
strategies  
Systematic 
literature reviews, 
qualitative 
interviews & 
 
4 diabetes care 
sites in Toronto 
were used 
Definition: inadequate 
or insecure access to 
food because of 
financial constraints 
 
Part 1: Choosing and 
piloting FI 
questionnaires with 
population  of interest, 
including qualitative 
interviews with 10 
patients and 15 care 
providers  
 
Single- and 2-item 
versions of HFSS were 
39% found to be food insecure 
 
71% patients were willing and 
comfortable to discuss their 
experiences with food insecurity 
with their healthcare provider 
 
Was found both relevant and non-
intrusive to discuss in healthcare 
setting. No embarrassment or 
negative reactions reported 
 
Perceived time barriers of the 
provider and discomfort with 
discussing financial hardship may 
Strengths 
Care algorithm based on 
systematic review of evidence 
 
Recruitment strategy well 
described and validated by 
participants 
 
Limitations  
Screen only for income-
associated FI as per HFSS 
 
Assumes poverty is root cause of 
FI 
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used to assess food 
consumption over last 
3 months 
 
Part 2:  
A systematic literature 
review to develop  a FI 
algorithm and 
guidelines for 
managing  individuals 
with DM 2 who are 
food insecure. 
 
Part 3:  
 
registered nurses& 
registered dietitians 
working in diabetes 
consented to the FI 
screening initiative to 
determining 
acceptability and 
feasibility of Part 2 by  
(a) employing initiative 
with  33 patients & 5 
care providers (b) 
Interviewing  
7 patients and 5 care 
providers to discuss 
acceptability and 
feasibility. 
 
Recruitment occurred  
by handing out flyers 
during diabetes classes 
or appointments and by 
using posters  
 
Participants were > 18 
years and were 
be barriers in patients choosing to 
disclose their FI status 
 
Strong rapport with a provider, 
perceiving the questions as 
important to their diabetes 
management and overall literacy 
increased the likelihood of 
answering the FI questions 
 
Screening elicited how patients 
cope with FI and how it affects 
diabetes self-management.  
 
Information provided was helpful to 
providers in guiding care and 
support for patients. 
 
Systematic review that informed FI 
algorithm encouraged the following 
assessment & management plan for 
individuals identified with FI: 
Assess 
 Medical history  
 Diabetes knowledge 
 Diabetes self-management 
skills 
 Mental health  
 Literacy level 
 Physical limitations   
 Housing  
 Financial support 
 Social support 
 Access to food 
 Cultural influences 
 Smoking habits 
 
Assess risk of hypoglycemia: 
Results limited to the experience 
of dieticians one RN screening, 
not PCPs 
 
Unclear how comfortable PCP 
feel discussing FI 
 
Unclear how often screening 
should occur, especially if 
temporarily food insecure 
 
Unsure if saturation of data 
reached vs screening was 
completed during a 
given/specific period of time 
 
CASP rating 
Moderate 
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diagnosed with 
diabetes 
 
Inductive qualitative 
approach used 
Interviewed audio-
recorded and coded in 
NVivo 
Thematic analysis used 
to recognize 
developing themes 
 
Consensus among 
researchers was used to 
recap final  set of 
themes 
 
 Review how to treat 
hypoglycemia  
 Replace glucose lowering 
medications that cause 
hypoglycemia 
 Schedule medications with 
meals 
 Consider a more flexible 
insulin regimen   
 Consider adjusting glycemic 
target upwards 
 
Management 
 Develop collaborative & 
realistic treatment plan 
 Encourage inclusion of family 
members in education  
 Consider client’s medication 
coverage 
 
Consider referrals:  
 Dietitian 
 Nurse 
 Social worker 
 Respiratory Therapist for 
smoking cessation  
 Local community food 
resources (food banks, 
community kitchens, low cost 
grocery stores)  
 Food skills classes  
 Assess if eligible for Special 
Diet Allowance funding  
 
Dietary management 
 Individualize nutrition 
recommendations based on the 
client’s budget, food skills, and 
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available food storage and 
cooking equipment   
 Provide information on low 
cost community foods 
recourses and meals  
 Provide low cost ideas for 
treating hypoglycemia 
 
Assessing for FI can assist health-
care providers in supporting 
diabetes self-management.  
 
Further evaluation needed to 
establish how FI  screening may 
improve a diabetes self-
management and outcomes. 
 
Important to acknowledge when 
screening may not be necessary or 
important.  
 
May bring meaning and 
understanding to providers why 
patients might not follow diabetes 
management recommendations. 
 
FI can be best addressed through 
income-based interventions. 
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Appendix C 
Food Insecurity Tools 
Screening Tool Purpose/ Intent Dimension 
measured 
Food Insecurity 
Level 
No. of 
Questions 
Sensitivity/ 
Specificity6 
Validated in 
Healthcare Setting? 
Comments 
Hager two-item 
screen 
Identifies income 
associated food 
insecurity  
Economic 
Access7  
 
Household 2 97% / 83% No   
Girard four-point 
tool 
Identifies income 
associated food 
insecurity 
Economic 
Access 
Household 
Individual 
4 n/a No  
Household Food 
Insecurity Access 
Scale (HFIAS) 
Measures access and 
Anxiety or uncertainty 
surrounding food 
supply 
Access to quality and 
variety of food 
Insufficient food 
intake and its physical 
consequences 
Economic 
Access 
Individual  9 n/a No  
Townsend Food 
Behaviour 
Checklist 
Identifies income 
associated food 
insecurity 
Economic 
Access  
Individual 2 n/a No  
Radimer/Cornell Identifies income 
associated food 
insecurity 
Economic 
Access 
Utilization 
Individual 8 n/a No Well analyzed in peer-
reviewed literature 
Modified 
Radimer/Cornell 
Identifies income 
associated food 
insecurity 
Economic 
Access 
Utilization 
Individual  10 n/a No Well analyzed in peer-
reviewed literature 
One-Item Hunger 
Screening 
Question  
Detect income-
associated food 
insecurity 
Economic 
Access 
Household 1 83% / 80% Yes  
                                                          
6 Diagnostic accuracy in capturing the specific dimension of food insecurity listed in each study. Note: studies have near exclusively determined this value by validating the tool against the HFSSM  
7 “Economic access” to food refers to access to food income-associated food insecurity 
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Two-Item 
Hunger 8Vital 
Sign (HVS) 
Detect income-
associated food 
insecurity and hunger 
for the purpose of 
linking screened 
individuals to 
resources 
Economic 
Access 
Household 2 89-97% / 
74-84% 
Yes  
Household 
Dietary Diversity 
Score (HDDS) 
Measures dietary 
diversity as a proxy 
for food security. 
Measures 12 different 
food groups 
Can be used to 
measure food security 
changes over time 
 
Food quality National 
Regional  
Household 
12  No  
Household Food 
Insecurity Access 
Scale 
(HFIAS) 
Used to measure FS at 
regional or household 
levels 
Used to monitor 
impact of 
interventions 
Anxiety  
Food 
Preferences 
Economic 
access 
Food quantity 
Regional 
Household 
9  No  
Household 
Hunger Scale 
(HHS) 
 
Measures hunger as a 
proxy for food 
security  
Can be repeated to 
measure the impact of 
interventions on 
hunger 
Economic 
Access 
Food quantity  
Regional 
Household 
3  No  
Core Food 
Security 
Measurement 
/Household Food 
Security Survey 
Module 
(CFSM/HFSSM) 
Measures 4 areas of 
IAFI:  
1) anxiety about 
household food 
supplies 
2) perceptions of 
accessibility to food 
quality or quantity  
Economic 
Access 
Anxiety  
Household 18  Yes Well analyzed in peer 
reviewed literature 
Gold standard 
                                                          
8 Note: Two-question short-form from HFSS tool 
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3) any reductions in 
food intake 
4) children’s reduced 
food intake  
Household Food 
Security Survey 
Module SF 
(HFSSM-sf) 
Validated short form 
of HFSSM to capture 
IAFI 
Economic 
Access 
Household 6 98%/ 92% Yes Well analyzed in peer 
reviewed literature  
American 
Academy of 
Pediatrics (AAP) 
Tool9 
Detect income-
associated food 
insecurity and hunger 
for the purpose of 
linking screened 
individuals to 
resources 
Economic 
Access 
Household 2 71%-82% / 
96%10 
Yes Comparative studies 
demonstrate AAP 
missed a quarter of 
food insecure 
individuals compared 
to HVS  
3-item Food 
Security tool11 
Adapted from the 
HFSSM to identify 
food insecurity 
amongst a diabetic 
population  
Economic 
Access 
Household 3 n/a No Not validated. Used 
for one pilot study 
Validated using 3 food 
secure and 3 food 
insecure individuals 
with DM 2 
Food Insecurity 
by Elders (FIE) 
Elderly augmented 
HFSSM 
 
Economic 
Access 
Physical 
Access 
Utilization 
Individual- 1412 89%/69% No Extra questions 
created based on one 
study’s findings 
 
 
                                                          
9 Validated against HVS, and does not specifically measure pediatric population 
10 Values reflect families without children 
11 Adapted using 3 questions from validated HFSSM. Not validated to identify food insecurity and no sensitivity/specificity testing. 
12 In addition to the HFSSM 
